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GLOSSARY 
OECD         : Organization for Economic Co-operation and Development 
CPCSEA      : Committee for the Purpose of Control and Supervision of  
   Experiments on Animals 
STZ            : Streptozotocin  
SGOT         : Serum Glutamic Oxaloacetic Transaminase 
ALP            : Alkaline Phosphatase 
TP              : Total Protein 
TC              : Total Cholesterol 
TG              : Triglycerides  
HDL            : High Density Lipoprotein  
LDL            : Low Density Lipoprotein  
VLDL         : Very Low Density Lipoprotein  
EtOH          : Ethanol 
EtAc           : Ethyl acetate 
PE              : Petroleum Ether   
 DPPH        : 2, 2-DiPhenyl-1-PicrylHydrazyl 
H2O2           : Hydrogen peroxide 
WHO          : World Health Organization 
TLC             : Thin Layer Chromatography 
UV               : Ultraviolet 
IR           : Infrared 
HPLC           : High Performance Liquid Chromatography 
MS                : Mass Spectroscopy 
GLC             : Gas Liquid Chromatography 
Rf                   : Relative retention time 
RSA               : Radical Scavenging Activity      
ADA               : American Diabetes Association 
GOD-POD     : Glucose oxidase – Peroxidase 
GC-MS           : Gas chromatography-Mass spectroscopy 
MAPs             : Medicinal and Aromatic Plants 
NIDDM          : Non insulin dependent diabetes mellitus 
HNF 4α          : Hepatic nuclear factor 4α 
HNF 1α          : Hepatic nuclear factor 1α 
FFA               : Formalin; Acetic acid; Ethanol  
HbA1c           : Haemoglubin A1c  
NaOH            : Sodium hydroxide 
SGPT             : Serum glutamic pyruvic transaminase 
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4. INTRODUCTION 
   People all over the world are now switching to alternative or herbal medicine for 
the treatment of various ailments. Herbal medicine is gaining popularity not just because of 
its effectiveness but also by clear marketing of the herbal drugs, describing them as ‘natural 
products’ which can not harm to humans. Healthy healing is an incredible resource for 
every patient. The interest in medicinal plants has increased due to the chronic disease. The 
Indian medicinal system viz. Ayurveda, Siddha and Unani system predominantly use plant 
based raw materials in most of their preparations and formulations. According to the World 
Health Organization, it is estimated that 80% of the population in the developing world rely 
on traditional medicines derived from medicinal plants. The plant based raw materials are 
safe, preventive, curative and are particularly useful in achieving the goal of “Health to All” 
in a cost effective manner.    
     “Whenever the art of medicine is loved 
                                              There also is love of humanity” 
- Hippocrates. 
Thus demand of medicinal plant is increasing in both developed and developing 
countries (Government of India, Planning Commission March, 2000). With the onset of 
scientific research in herbals it is becoming clearer that medicinal plants have a potential in 
today’s synthetic era. So the ancient knowledge coupled with scientific principles can 
come into the forefront and provide us powerful remedies to treat different diseases1. The 
WHO in its 29th and 30th assembly gave formal recognition to the traditional medicine. 
Pharmaceuticals are prohibitively expensive for most of the world’s population, half of 
which lived on less than $2 U. S. per day in 20022. Use of herbal medicine and herbal 
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treatment of diseases are on the increase even in the developed countries like Australia, 
Sweden, Switzerland and Canada3.  
HERBAL MEDICINE IN INDIA 
India stands first among all the Asian countries in having the knowledge on 
traditional system related to the use of plant species and diversity of higher plant species, 
which is the reason for the use of herbs in different forms in alternative systems of 
medicine. India has about 45,000 plant species. This huge number of medicinal plants 
species possess important role in health system. Among these, several thousand plants have 
been claimed to possess medicinal properties. Although herbal medicine are used in 
various ailments, often these drugs are improperly used and only few of them have got 
scientifically documented. Hence plant drug need a detailed study in the light of modern 
medicine in bringing new herbal chemical entities4-13.  
Origin  
Plants, animals and human beings have intimate biological relationships for their 
very basic needs like air, food, fire and fuel, since remote past. The primitive men during 
the course of their struggle in the forest under the circumstances of object poverty disease 
and hunger. To liberate themselves from these suffering they should have looked towards 
the nature (i.e.) plants and this inevitably led to trial and error experimentation and 
discovery of the healing properties of plants by using wild animals. As time went on, each 
tribe added the medicinal power of herbs in their area to its knowledge base. They 
methodically collected the information on herbs and developed well-defined herbal 
pharmacopeia. In 20th century, the pharmacopoeia of scientific medicine was derived from 
the herbal lore of native peoples. Many drugs commonly used today are of herbal origin. 
About 25% of the prescription drugs dispensed from plant material14-16.  
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Importance  
The natural to assume that plants were not only eaten for food but were also used as 
a source of medicine. Although written and pictorial records of herbalism cover no more 
than the past 5,000 to 6,000 years, archeologically records clearly show that the knowledge 
and practise of herbal medicine was highly developed long before the earliest written 
accounts known to us were made. Plants form the major healing powers in almost all 
ancient civilization like Egyptian, Chinese, India, Roman and Greek1. 
Foods and herbs as medicine 
The majority of medicinal plants found in the world grow wild. As natural habitats 
worldwide are degraded, overexploited and destroyed, many plants species including 
medicinal plants face threats to their survival. It is becoming increasingly important to take 
care of the areas in which they grow and to share knowledge about their usefulness. 
Involving local people from areas where the plants grow is crucial. In the India many 
people rely on plants and plant – products for food, medicine and shelter. We need to 
balance health first through proper nutrition with the help of herbs serving as special foods 
for both body and mind17.  
Wide spread demand for medicinal plants 
The pecuniary value of MAPs related to global trade at over 60 billion USD (Govt. 
of India, 2000). Popularity increased for medicinal plants, both South Asia and 
Internationally, this trade is expected to grow to 5 trillion by the year 2050 (FRLHT, 
1996). Moreover health benefits, MAPs provide crucial livelihood options for millions of 
rural people in South Asia, particularly women, tribal people and the very poor17. 
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Scientific approach to the herbal medicine 
The technology involving extraction, purification and characterization of 
pharmaceuticals from natural sources is a significant contribution to the advancement of 
natural and physical sciences. The rapid development of phytochemistry and 
pharmacological testing methods in recent years, new plant drugs is finding their way into 
medicine as a purified phytochemicals, rather than in the form of traditional galenical 
preparations. Phytopharmaceuticals or synthetic drugs derived from phytochemicals have 
to be ultimately incorporated in suitable dosage form which involves the knowledge of 
dispensing and preparative pharmacy, pharmaceutical technology and analysis.  
Pharmacognosy is a vital link between Ayurvedic and Allopathic systems of 
medicines. It provides a system wherein the active principles of crude drugs derived from 
natural origin can could be dispensed, formulated and manufactured in dosage forms 
acceptable to the Allopathic system of medicine18. 
DIABETES MELLITUS 
Diabetes mellitus is a group of metabolic diseases characterized by chronic 
hyperglycaemia associated with disturbances of carbohydrate, fat and protein metabolism 
due to absolute or relative deficiency in insulin secretion and/ or action. Diabetes causes 
long term damage, dysfunction and failure of various organs; especially the eyes, kidneys, 
nerves, heart and blood vessels. 
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                                                         Fig. 1 Pancreas 
Diabetes is not a single disease; rather it is a heterogeneous group of syndromes 
characterized by an elevation of blood glucose caused by relative or absolute deficiency of 
insulin19. 
Epidemiology of diabetes 
The incidence of diabetic is growing rapidly in United States and worldwide. 
Globally as of 2010, an estimated 285 million people had diabetes, with type II making up 
about 90% of the cases20. In 2013, according to International Diabetes Federation an 
estimated 381 million people had diabetes21-22, its prevalence is increasing rapidly. It is 
estimated that more than 250 million people worldwide are afflicted with diabetes and the 
prevalence is expected to exceed 350 million by the year 20301. 
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Symptoms of diabetes1 
Common symptoms include the following: 
  Frequent urination 
  Excessive thirst 
  Unexplained weight loss 
  Sudden vision changes 
 Head ache, fatigue, lethargy 
 Muscle cramps, irritability, emotional liability 
 Abdominal discomfort 
Types of diabetes20 
The ADA recognizes four clinical classification of diabetes 
 Type - I diabetes (insulin dependent diabetes mellitus) 
  Type - II diabetes (formerly, non-insulin dependent diabetes mellitus) 
 Gestational diabetes (first recognition during pregnancy)  
  Diabetes due to other causes (genetic defects or medication) 
Type I diabetes  
Type 1 diabetes is called as insulin-dependent diabetes. It is also represented as 
juvenile-onset diabetes, because it often begins in childhood. Type 1 diabetes most 
commonly afflicts individuals in puberty or early adulthood. The disease is characterized 
by an absolute deficiency of insulin caused by massive β-cell necrosis. In all type1 cases 
circulating insulin levels are low or very low and patients are more prone to ketosis. This 
type is less common and has a low degree of disposition19-20.  
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                  Fig. 2 Type 1 diabetes 
Type II diabetes 
Type 2 diabetes (NIDDM) is influenced by genetic factors, aging, obesity and 
peripheral insulin resistance, rather than by autoimmune processes or viruses. Over 90% 
cases are type 2 diabetes mellitus. Type 2 diabetes is frequently accompanied by the lack 
of target organs to either endogenous or exogenous insulin. This insulin is considered as 
major cause of this type 2 diabetes19-20.                            
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                                                  Fig. 3 Type II diabetes                 
Gestational diabetes 
Diabetes that's triggered by pregnancy is called gestational diabetes (pregnancy, to 
some degree, leads to insulin resistance). It is often diagnosed in middle or late pregnancy. 
Because high blood sugar levels in a mother are circulated through the placenta to the 
baby, gestational diabetes must be controlled to protect the baby's growth and 
development. The rate of gestational diabetes is between 2% to 10% of pregnancies. 
Gestational diabetes usually resolves itself after pregnancy. Up to 10% of women with 
gestational diabetes develop type 2 diabetes19-20. 
 
PATHOPHYSIOLOGY 
Pancreas 
The hormones play an important role in regulating the metabolic activities of the 
body, particularly the homeostasis of blood glucose. The pancreas is both an endocrine and 
exocrine gland, in which endocrine produces the peptide hormone insulin, glucagon and 
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somatostatin and exocrine gland produces digestive enzymes.  The peptide hormones are 
secreted from cells located in the islet of langerhans (β cells produce insulin, alpha cells 
produces glucagon and δ cells produce somatostatin)19-20. 
 
 
                                            Fig. 4 Langerhans  
Genes of diabetes mellitus1  
Two genes called “MODY 1” and “MODY III” that appear to contribute to the 2% 
to 5% of diabetes, that are clearly inheritable. 
MODY I GENE 
Mody I gene is located on chromosome 20, makes hepatocyte nuclear factor -4α 
(HNF, 4α) a cell receptor that plays a role in HNF - 4α production. 
MODY II GENE 
Mody II gene is located on chromosome 12 produces hepatocyte nuclear factor-1α 
(HNF, 1α) a protein found in the liver and β cells of the process.   
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Insulin19-20  
Insulin was discovered in 1921 by Banting and best who demonstrated the 
hypoglycaemic action of an extract of pancreas. In 1922 an extract containing insulin was 
first used on a 14 year old boy suffering from severe diabetes mellitus with excellent 
response. Insulin was then purified in a few years. 
Chemistry, synthesis and secretion 
The islets of langerhans are composed of 4 types of β cells secrete insulin, alpha 
cells glucagon, δ cells somatostatin and P cells secrete pancreatic polypeptide. Glucose 
enters the pancreatic β cells with the help of glucose transporters.  
 
                                                     Fig. 5 Secretion of insulin in β cells 
Insulin is released from the granules by a process of exocytosis. Natural insulin is a 
polypeptide synthesized from the precursor preproinsulin which is cleaved to get 
proinsulin. Proinsulin is processed in the secretary granules to get insulin. It has two 
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peptide chains-A chain (21 amino acid) and B chain (30 amino acid) linked by disulphide 
bridges.                 
 
                                                Fig. 6 Structure of insulin  
  Insulin is stored in granules in the β islets cells of the pancreas. Normal pancreas 
releases about 40 to 50 units of insulin every day. Basal insulin secretion is 0.5-1U/hr and 
increase after meals up to 6U/hr. Insulin is metabolised in the liver, kidney and muscle.  
 
                     Fig. 7 Insulin release from β islets cells of the pancreas 
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 Mechanism of action  
Insulin acts by specific receptors. Insulin receptor is a glycoprotein made up of two 
α and β subunits. Insulin binds to the alpha subunit of the receptors present on the surface 
of target cells. This binding stimulates tyrosine kinase activity in the β subunit. This in turn 
activates a cascade of phosphorylation and dephosphorylation reactions which stimulate or 
inhibit the enzymes involved in the metabolic actions of insulin.  
 
 
 
                                   Fig. 8 Mechanism of action of insulin 
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The following table provides information about the characteristic of different types 
of insulin and characteristic23 
Table 1. Types of insulin and characteristics 
             Insulin Onset (hr) Peak (hr) Duration (hr) 
A. Rapid acting  
Lispro 
Asparte 
Glusiline 
 
 
0.25-0.5 
10 -20 min 
5-15 min 
 
0.5-2.5 
1-3 
30- 45 min 
 
3-6.5 
3-5 
2- 4 
B. Short acting 
Regular 
 
0.5-1 
 
1- 5 
 
6- 10 
C. Intermediate acting 
NPH (human) 
Lente (human) 
 
1-2 
2-4 
 
6-14 
4-12 
 
18 - > 24 
12-18 
D. Long acting 
Ultralenete (human) 
Glargine 
 
6-10 
3-4 
 
10-6 
    - 
 
18-24 
20-24 
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Actions of insulin19 
 Insulin target on various organs such as liver, muscles and adipose tissue have been 
showed on Table. 2 
Table 2. Insulin act on various organs   
Liver Muscle Adipose tissue 
Increased glucose uptake 
and glycogen synthesis 
Increased glucose uptake 
and utilization 
Increased glucose uptake 
and storage as fat and 
glycogen 
Inhibits glycogenolysis and 
glucose output. Inhibits 
gluconeogenesis from 
protein, pyruvate, FFA and 
glycerol 
Inhibits proteolysis and 
release of amino acids, 
pyruvate, lactate into blood 
which forms substrate for 
gluconeogenesis in liver 
Inhibits lipolysis  and 
release of FFA + glycerol 
which forms substrate for 
gluconeogenesis in liver 
 
TREATMENT OF DIABETES MELLITUS 
The goal of diabetes management is to keep blood glucose levels as close to normal 
as safely possible. Since diabetes may greatly increase risk for heart disease and peripheral 
artery disease, measures to control blood pressure and cholesterol levels are an essential 
part of diabetes treatment as well24. 
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Type I diabetes treatment  
A person with type 1 diabetes must rely on exogenous (injected) insulin to control 
hyperglycemia, avoid ketoacidosis and maintain acceptable levels of glycosylated 
haemoglobin (HbA1c). The use of home blood glucose monitors facilitates frequent self-
monitoring and treatment with insulin injections. Continuous subcutaneous insulin infusion 
is another method of insulin delivery (insulin pump). The pump is programmed to deliver a 
basal rate of insulin secretion and it also allows the patient to control delivery of a bolus of 
insulin to compensate for high blood glucose.  
Other methods of insulin delivery such as transdermal, buccal and intranasal are 
currently investigation. Amylin is a hormone that is co secreted with insulin from 
pancreatic β cells following food intake. Pramlintide a synthetic analogue of amylin may 
be used as an adjunct to insulin therapy.   
Type II diabetes treatment  
Treating type 2 diabetes is maintaining blood glucose concentrations within normal 
limits and to prevent the development of long-term complications of the disease. Weight 
reduction, exercise and dietary modification decrease insulin resistance and correct the 
hyperglycemia of type 2 diabetes in some patients. As the disease progresses, β cell 
function declines and insulin therapy is often required to achieve satisfactory serum 
glucose levels.  
Gestational diabetes treatment 
 Treatment during pregnancy includes working closely with your health care team  
 Careful meal planning to ensure adequate pregnancy nutrients without excess fat 
and calories 
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 Daily exercise 
  Controlling pregnancy weight gain 
  Taking diabetes insulin to control blood sugar levels if needed.       
 
MANAGEMENT OF DIABETES MELLITUS1,19-20 
Glycemic Control 
There are two primary techniques available to assess the quality of a patient’s glycemic 
control 
 Self - monitoring of blood glucose (SMBG) and 
 Interval measurement of haemoglobin A1C (HbA1c). 
Self-Monitoring of Blood Glucose 
SMBG is an effective way to evaluate short-term glycaemia control. It helps to 
monitor the effect of food, medications, stress, and activity on blood glucose levels of 
patients. The frequency of checking helps to prevent the risk factor and to maintain the 
medical therapy. For patients with type 1 and type 2 diabetes mellitus, self monitors their 
glucose at least three times per day. Initially some patients require more frequent 
monitoring, including both pre-prandial and postprandial readings.  
Patients with gestational diabetes who are taking insulin should monitor their blood 
glucose three or more times daily. But also the inclusion of health-improving behaviour 
such as diet and exercise maintained. For pregnant women, glucose levels of 60 to 99 
mg/dL and peak postprandial levels between 100 and 129 mg/dL. 
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Haemoglobin A1c 
HbA1c measures no reversible glycosylation of the haemoglobin molecule, which 
is directly related to blood glucose concentrations. Periodic testing is recommended in all 
patients with diabetes. The ADA recommends that patients with stable glycaemia control 
be tested at least twice a year. The frequency of testing depends on the clinical situation 
and the patient’s treatment regimen. 
Other management methods are, 
 Goals of therapy 
 Patient and family education  
 Nutrition  
 Fibre  
 Alcohol  
 Artificial sweeteners 
 Exercise 
Synthetic drug treatment25-27 
When considering appropriate pharmacologic therapy, a major factor to consider is 
whether the patient is insulin deficient, insulin resistant, or both. Treatment options can be 
divided into insulin sensitizers, secretagogues, α glucosidase inhibitors, incretins, 
pramlintide, SGLT-2 inhibitors, insulin and insulin analogs. 
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Table 3. Pharmacological treatment 
Subgroup 
 
Generic 
Name(Brand) 
 
Class Route Comments 
Biguanides 
 
Metformin 
(Glucophage) 
 
Sensitizer Oral 
Weight loss 
No 
hypoglycemia 
Thiazolidinediones 
 
 
Rosiglitazone, 
(Avandia) 
Pioglitazone, (Actos) 
Sensitizer Oral 
Weight gain 
Peripheral 
edema 
Alpha glucosidase 
Inhibitors 
Acarbose (Precose), 
Miglitol (Glyset) 
Sensitizer 
 
Oral 
GI upset 
No 
Hypoglycaemia 
Sulfonylureas 
Glimepiride(Amaryl) 
(Orinase), Glipizide 
(Glucotrol), 
Tolazamide 
(Tolinase), 
Tolbutamide 
Sensitizer 
 
Oral Hypoglycemia Weight gain 
Glinides 
Nateglinide (Starlix), 
Repaglinide 
(Prandin) 
Sensitizer Oral Weight gain 
Exenatide Byetta 
 
GLP-1 
analog Subcutaneous 
Weight loss 
GI upset 
Liraglutide Victoza 
 
GLP-1 
analog Subcutaneous 
Weight loss 
Nausea 
Extended release 
exenatide 
 
Bydureon GLP-1 
analog Subcutaneous 
Weight loss 
Nausea 
Pramlintide 
 
Symlin Incretin Subcutaneous 
GI upset 
Adjunctive 
therapy with 
insulin 
Dipeptidyl 
peptidase-4 
inhibitors (DPP- 
4s) 
Sitagliptin (Januvia), 
Saxagliptin 
(Onglyza), 
Linagliptin (Trajenta) 
DPP-4 
Inhibitors Oral 
No 
hypoglycemia 
Nasopharyngitis 
Weight neutral 
SGLT-2 inhibitors 
Canagliflozin 
(Invokana) 
Dapagliflozin 
Renal 
Glycosuria Oral 
Oral Polyuria 
UTIs 
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ALTERNATIVE MEDICINE FOR DIABETES1 
The early developing phase of modern medicine relied on herbs as a major source 
of drugs. With years of extensive research and isolation of the active agents, herbs had 
given way to the ‘pills of modern medicine’. With immense flora present on the earth, one 
cannot keep a track of all the herbs and so there can be many herbs and plants whose 
products may be beneficial in treating disease. Such herbs or plant products should be 
analysed for their active ingredients which can be used for the manufacture of future drugs. 
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Table 4. Antidiabetic plants and their curative properties  
S. No Botanical name Common 
name 
Family Uses 
1. Abelmoschus 
esculentus 
Bhindi Malvaceae 2 fresh seedless tender 
fruits are given twice 
daily till cure 
2. Buchanania lanzan Piyar Anacardiaceae Power of leaf or seed 
helps in controlling 
glucose levels at early 
stage of diabetes 
3. Cyperus triceps Nirbishi Cyperaceae 10 ml of root decoction 
is given during 
excessive thirst caused 
due to diabetes 
4. Daucus carota Gajar Apiaceae 1 teaspoonful of root 
powder is given twice a 
day with hot water for 
20 days 
5. Enicostemma 
axillare 
Nagaguha Genetianaceae Whole plant is used till 
cure 
6. Feronia limonia Wood apple Rutaceae Leaves powder is useful 
if it is taken on empty 
stomach every day for 
30 days 
7. Gossypium 
herbaceum 
Kapas Malvaceae 5 ml of decoction of the 
seeds is taken orally 2 
times a day for 40 days 
8. Hordeum vulgare Barley Poaceae 1 or 2 chapati’s are 
taken daily till cure 
9. Indigofera arrecta Bengal indigo Papilionaceae Root powder is taken 3 
times a daily till cure 
10. Ipomaea maxima - Convolvulaceae 10 g of roots is made 
into a paste and given 
with sugar candy twice 
daily for 2 – 3 days 
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As practitioners of evidence based modern medicine, most physicians believe that 
herbal products could be effectively used for treating disease only after these products are 
thoroughly tested for the benefits and validated for medicinal use by the concerned 
agencies. For all these reasons herbs should be taken with care under the supervision of 
practitioner knowledge in the field of botanical medicine. Folkloric uses are supported by a 
long history of human experience. Numerous biologically active plants are discovered by 
evaluation of ethno pharmacological data and these plants may offer the local population 
immediately accessible therapeutic products. 
Although more than 1000 plants have been claimed to offer special benefits in the 
treatment of diabetes, few have received details scientific investigation, leaving scope for 
extensive further work. 
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2. REVIEW OF LITERATURE 
Pharmacognostical review 
1. Sarojini sarangapani et al ., (2012) carried out the Pharmacognostical study on 
Delonix regia seed polymer.28 
2. Barhate. A. N et al ., (2014) carried out the Pharmacognostical study on Delonix 
regia seed gum.29 
Phytochemical review 
3. Kavitha Sama et al ., (2011) the root bark of Delonix regia possess tannin, 
terpenoid, sterol, glycoside, alkaloid, phenol.30 
4. Samar. S et al ., (2012) carried out phytochemical analysis showed on Delonix 
regia leaves and reported the isolation of seven flavonoidal glycosides.31 
5. Ravi Kumar. A et al ., (2013) the investigation of the Delonix regia leaves contains 
carbohydrate, alkaloid, flavonoid, cardiac glycoside, anthroquinone glycoside, 
saponins, steroid and tannin.32   
6. Fatmawaty et al., (2013) bark, leaf and peel extract have alkaloid compounds. 
Flavonoids found in flowers, phenolic compounds found in Bark and flower of 
Delonix regia.33 
7. Anindita Biswas et al ., (2014) the phytochemical analysis on Delonix regia flower 
bearer alkaloid, flavonoid, sterol, saponin, protein, amino acid, carbohydrate, 
glycoside, carotenoid, tannin, and phenolic compounds.34   
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8. Rajabhau S Shiramane et al ., (2011) reported the phytochemical investigation is 
showed the Delonix regia flowers possess carbohydrate, flavonoid, saponins 
glycoside, tannin and steroid.35 
9. Nilam Yadao et al ., (2015) reported the phytochemical analysis showed the 
Delonix regia leaves possess carbohydrate, flavonoid, saponins and tannin.36 
10. Mariajancyrani J et al ., (2013) reported the phytochemical analysis showed the 
Delonix regia leaves possess flavonoid, sterol and glycoside.37 
11.  Mohd Asif Khan et al ., (2012) reported the phytochemical analysis showed the 
Delonix regia flowers possess carbohydrate, flavonoid, saponins, tannin and 
steroid.38 
12. Ghulam Shabir et al ., (2011) reported the quantitative analysis showed the Delonix 
regia leaves, flowers and bark possess phenolic acids.39 
13. Shanmukha I et al ., (2011) reported the phytochemical analysis showed the 
Delonix regia flowers possess protein, alkaloid, flavonoid, tannin and phenolic 
compound. Also reported the total phenolic content.40 
14. Consolaction Y. Ragasa etal (2011) reported the Delonix regia leaves chemical 
structure was deducted.41 
15. Aly M. El – sayed et al ., (2011) reported the Delonix regia flowers chemical 
structure was established by spectral analysis.42 
16. Joythi M. Veigas et al ., (2007) reported the Delonix regia floral petals possess 
polyphenols compounds was estimated by total quantification phytochemicals.43 
17. Sarojini sarangapani et al ., (2012) reported the phytochemical analysis showed the 
Delonix regia seed polymer possess carbohydrate, alkaloid, steroid, flavonoid, 
terpenoid, glycoside, sapponin, tannin and fixed oil.44  
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18. Barhate. A. N et al ., (2014) reported the physicochemical characterization of       
Delonix regia seed gum for pharmaceutical suspension.45 
19. Felix Adje et al ., (2008) reported the Delonix regia flowers bio molecular 
composition, for pilot – plant scale membrane technology.46     
Pharmacological review 
20. Rajabhau S Shiramane et al ., (2011) reported the Invivo Antidiarrhoeal activity on 
Delonix regia flowers.47    
21. Fatmawaty et al ., (2013) carried out Antimalarial activity on Delonix regia leaves, 
bark, seeds and flowers.48 
22. Rozina Paul et al ., (2014) carried out Antinociceptive and cytotoxic activity on 
Delonix regia leaves.49 
23. Nilam Yadao et al ., (2015) carried out Antidiabetic and antioxidant activity on 
Delonix regia leaves.50 
24. Kavitha Sama et al ., (2012) carried out Antibacterial activity on Delonix regia root 
bark.51 
25. Sachidanandha Swamy H. C et al ., (2014) carried out Antibacterial activity on 
Delonix regia flowers. 52 
26. Dinanath D Patil et al ., (2014) carried out Antibacterial and anti – inflammatory 
activity on Delonix regia leaves and roots.53 
27. Shiramane Rajabhu S et al ., (2011) carried out Gastroprotective activity on 
Deloninx regia flowers.54 
28. Anindita Biswas et al ., (2014) carried out Hepatoprotective activity on Delonix 
regia flowers.55 
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29. Ahmed Salman et al ., (2012) carried out Antiemetic activity on Delonix regia 
leaves.56 
30. Vivek M.` N et al ., (2013) carried out Antimicrobial activity on Delonix regia 
leaves and flowers.57 
31. Mohd Asif Kan et al ., (2012) carried out Wound healing activity on Delonix regia 
flowers.58 
32. Tagalpallewar. V. R. et al ., (2014) carried out Antidiabetic activity on Delonix 
regia leaves.59 
33. Ghulam Shabir et al ., (2011) carried out Antimicrobial activity on Delonix regia 
leaves, flowers and bark.60 
34. Mohamed Z. M. Salem et al ., (2014) carried out Antibacterial and anti fungal 
activity on Delonix regia stem wood and bark.61 
35. Ode O. J et al ., (2013) carried out Antidiarrhoeal activity on Delonix regia root 
bark.62 
36. Consolacion Y. Ragasa et al ., (2011) carried out Antimicrobial activity on Delonix 
regia leaves.63 
37. Samaresh Pal Roy et al ., (2013) carried out Antiulcer activity on Delonix regia 
flowers.64 
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3.  ETHNOBOTANICAL SURVEY65-68 
 
PLANT PROFILE 
Plant name           :  Delonix regia (Boojer .Hook.) Raf.  
Common name   :  Royal Poinciana. 
Synonym            :  Poiniana regia.  
Family                               :  Leguminosae. 
Vernacular names 
English                                   :     Flamboyant flame tree, Flame of the forest,  
  Gulmohar 
Arabic                                    :     Goldmore  
French                                    :     Flamboyant, Poinciana,royal 
Burmese                               :     Seinban 
Spanish                 :    Acacia roja 
Swahili                     :  Mjohoro, mkakaya 
Hindi                     :  Gulmohr 
Bengali                         :  Chura, radha  
Tamil           :  Mayarum, mayirkonrai, Perugondrai 
Taxonomical status 
Kingdom :  Plantae 
Phylum         :  Magnoliophyta 
Class :        Magnoliophyta 
Order     :  Fabales 
Ethnobotanical survey 
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Family :  Leguminosae 
Subfamily        :  Fabales 
Genus       :  Delonix 
Species         :  Delonix regia  
Origin 
 Madagascar and Zambia. 
Exotic  
 Brazil, Egypt, India, Kenya Niger, Cyprus, Sri Lanka, South Africa, Uganda, 
United States of America and Jamaica. 
Habitat 
 The ornamental plant, found in road side and forest. 
Habit 
 Delonix regia (Boojer .Hook.) Raf. Tree is 40 feet in height having umbrella like 
canopy can be wider than its height. 
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BIOGRAPHY OF THE PLANT          
 
Fig .9 Delonix regia (Boojer .Hook.) Raf. Tree 
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PLANT DESCRIPTION  
Delonix regia (Boojer. Hook.) Raf., is native to Madagascar, where it is almost 
extinct. This plant is now widespread in most tropical and subtropical areas. Plant can 
grow at higher altitudes than recommended, but flowering become irregular69. 
 
Seeds70, 28   
Seeds are speckled, rather like a fava bean. Typical of most hard seeded legumes, 
hard, greyish, glossy, to 2 cm long, oblong and shaped very much like date seeds 
                                    
 
                                                 Fig .10 Delonix regia seeds 
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Bark65 
Smooth, greyish-brown, slightly cracked and having many lenticels; inner bark is 
lightbrown. 
             
                                                    Fig .11 Delonix regia bark  
Leaves 64,71- 72 
The compound leaves have a feathery appearance and are a characteristic light, 
alternate, bright green. Leaflets - Each  bearing 12-40 pairs of small oblong-obtuse leaflets 
that are about 0.5-2 cm long and 0.3 cm wide; petiole stout. 
              
         Fig. 12 Delonix regia leaves 
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Flowers73-74 
Flowers 5-13 cm across, with 5 equal petals, on slender stalks 5-7.6 cm long. 
             
           Fig.13 Delonix regia flowers 
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Fruits67  
Fruit green and flaccid when young, turning to dark brown, hard, woody pods, 30-
75 cm long, 3.8 cm thick, 5-7.6 cm broad, with many horizontally partitioned seed 
chambers inside,    indehiscent, finally splitting into 2 parts.            
 
 
          Fig. 14 Delonix regia fruits  
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Ethanobotanical use44 
Table 5. Ethanobotanical use 
Delonix regia (Boojer .Hook.) Raf. Ethanobotanical use 
Leaves Antidiabetic, anti-inflammatory, antimicrobial 
activity 
Flowers Antidiarrhoeal, anthelminitic, wound healing, Gastroprotective activity 
Leaves, flowers and barks Antioxidant activity 
Seeds Antidiabetic activity 
Aerial parts Hepatoprotective activity 
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4. RATIONALE FOR SELECTION 
 Diabetes mellitus is a debilitating and often life threatening disease with 
increasing incidence throughout the world. Diabetes complications arise partly from 
glycosylation damage to structural and functional protein and reflect chronic failure to 
maintain blood glucose homeostasis.  
In addition to hyperglycaemia, several other factors such as dyslipidemia or 
hyperlipidemia are involved in the development of cardiovascular complications of 
diabetes by which 30-40% of diabetic population eventually develop end stage renal 
failure. Also increased oxidative stress is a widely accepted factor in the progress of 
diabetes and its complications. Almost 80% of deaths occur in low and middle-income 
countries. Synthetic drugs used for diabetes have produced adverse effects using longer 
time when compared to herbal drugs. 
Nowadays plants are being upgraded by validating the traditional claims and 
establishing its medicinal value. Various parts of the plants are yet to be scientifically 
proven for their therapeutic efficacy. The antidiabetic activity was not scientifically 
validated on seeds. 
 Delonix regia (Boojer .Hook.) Raf., with agricultural and botanical limits, efforts 
were undertaken to unmask the extremely useful yet hidden therapeutic potential 
of the plant. 
 The ethanomedicinal uses claimed were antidiarrhoeal, anti-inflammatory, 
hepatoprotective antioxidant, antimicrobial, anthelminitic, wound healing and 
gastroprotective activity and antidiabetic activity.      
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 No pharmacognostical and phytochemical work has been carried out on the seeds 
so far. 
 The Antidiabetic activity was not yet scientifically validated.  
 So the seed of the plant Delonix regia (Boojer .Hook.) Raf., was selected for 
evaluation of antidiabetic activity. 
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5. AIM AND OBJECTIVE 
 In the present scenario many countries in the world started giving importance for 
their own traditional and tribal medicines. The available treatment is only palliative and 
need to be taken almost life long. 
 Considering the side effects and other complications caused by the modern drug 
therapy, natural medicine is attracting increasing number of people. 
AIM 
The present study is to explore the Pharmacognostical, Phytochemical and 
Pharmacological studies on the seeds of Delonix regia (Boojer .Hook.) Raf.  
OBJECTIVE 
 Collection and authentication of the plant specimen. 
 Establishing the pharmacognostical profile of the plant.  
 Extraction of plant materials, to prepare various extracts of Delonix regia (Boojer 
.Hook.) Raf., seeds (hexane, ethyl acetate, ethanol, water).  
  Phytochemical screening of the crude powder and various extracts. 
 To evaluate an in vitro antioxidant activity to identify the active extract. 
 To evaluate the in vitro & invivo antidiabetic activity of the active extract.  
 To isolate the active constituent present in the active extract using column 
chromatography. 
 To characterize the isolated compounds by spectral studies like IR and GC – MS 
spectroscopy. 
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6. PLAN OF WORK 
 PHARMACOGNOSTICAL STUDIES 
 Collection and Authentication of plant material. 
 Macroscopy.  
 Microscopy. 
 Powder microscopy. 
 Linear measurement. 
 Histochemical studies. 
 Physicochemical constants.  
 Qualitative analysis of heavy metals and inorganic elements. 
 Quantitative estimation of heavy metals and inorganic elements. 
PHYTOCHEMICAL STUDIES 
 Preparation of extracts. 
 Fluorescence analysis of powder and extracts. 
 Preliminary phytochemical screening of powder and extracts. 
 Quantitative estimation of phytoconstituents. 
 Thin layer chromatography of extracts.  
 High performance Thin Layer Chromatography of extracts. 
PHARMACOLOGICAL STUDIEDS 
 In vitro studies selection of active extract. 
a. In vitro Antioxidant activity.  
1,2 – Diphenyl – 2- Picryl Hydrazyl radical scavenging assay. 
b. In vivo Antidiabetic activity. 
α-Amylase Inhibition assay. 
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 In vivo evaluation of Antidiabetic activity. 
a. Acute toxicity study. 
b. Streptozotocin induced Hyperglycaemic.  
c. Collection of blood and organs. 
d. Histopathological study. 
e. Statistical analysis.    
ISOLATION OF ACTIVE COMPOUNDS  
 Isolation of compounds from active extract.  
 Infra red spectroscopy of isolated compounds. 
 GC – MS spectroscopy analysis of isolated compounds. 
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7. MATERIALS AND METHODS 
PHARMACOGNOSTICAL STUDIES 
Collection and authentication of plant material 
The seeds of Delonix regia (Hook.) Raf., was collected from Nungambakkam, 
Chennai-03, Tamil Nadu in July-2015. The plant material was confirmed and authenticated 
by Dr. M. Palanisamy, Scientist ‘D’- In – Charge, Botanical Survey of India, Southern 
Regional Centre, T. N. A. U Campus, Lawley Road, Coimbatore-641003. The specimen 
copy of this plant is preserved in the Department of Pharmacognosy herbarium to future 
reference. The voucher number is 14/PCOG/2015.  
MACROSOPY 75  
The plant material is categorized according to sensory characteristics. Organoleptic 
evaluation provides the simplest and quickest means to establish the identity, purity and 
quality of a particular sample. Hence this observation is of primary important before any 
further testing can be carried out. 
MICROSCOPY 
Staining method   
a. Fixation of plant material76 
The sample or seed was cut fixed in FAA solution (Formalin 5ml + Acetic acid 5ml 
+ 90ml of 70% Ethanol). The specimen was dehydrated after 24 hours of fixing. The seeds 
were graded with series of tertiary butyl alcohol, as per the standard method. 
Materials and methods 
 
Dept. Of Pharmacognosy, MMC. Page 40 
 
 
b. Infiltration of the specimen77 
It was carried out by gradual addition of 58 - 60°C of melting pointed paraffin wax 
until Tertiary Butyl Alcohol (TBA) solution attained super saturation. The specimens were 
cast into paraffin blocks. 
Sectioning78   
The paraffin embedded specimens were sectioned with the help of Rotary 
microtome. The thickness of the sections was 10 - 12µ. Dewaxing of the sections was done 
by customary procedures. The sections were stained Toludine blue. Since toludine blue is a 
polychromatic stain, the sections were stained as per the method published by O’Brein et 
al. The staining results were remarkably good. The dye rendered pink colour to the 
cellulose walls, blue to the lignified cells, dark green to subrein, violet to mucilage and 
blue to the protein bodies. Whenever necessary sections were also stained with safranin, 
fast green and iodine for starch.  
PHOTOGRAPHS 
Microscopic descriptions were supplemented with photo micrographs whenever 
necessary. Photographs of different magnifications were taken with Samsung, lab photo 
two microscopic units. For normal observations bright field was used. 
For the study of crystals and lignified cells, polarized light was employed. Since, 
these structures have birefringent property under polarized light they appear bright against 
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dark background. Descriptive terms of the anatomical features are as given in the standard 
anatomy books.  
POWDER MICROSCOPY 79-81 
The shade dried, powdered plant material was used for powder microscopic 
analysis. The Organoleptic characters were observed and to identify the different 
characteristic features various staining reagent were used. Powder was stained with 1% 
phloroglucinol in 90% ethanol, concentrated hydrochloric acid and observed through 
microscope. All the lignified cells stained with pink colour. 
HISTOCHEMICAL STUDIES 82 
Portions of fresh seeds of the plant of Delonix regia (Boojer .Hook.) Raf., was 
used. The seeds were soaked in Formalin, Acetic acid, Ethanol before taking the section. 
The sections were stained using specific reagents (N/50 Iodine, dilute ferric chloride, 
phloroglucinol and concentrated hydrochloric acid. Picric acid, Dragendroff’s reagent and 
O- toludine blue) to observe and locate starch, lignin, tannin, protein, alkaloid and 
flavonoid respectively as per the protocols. The stained sections were then washed in water 
to remove the excess stain and observed under a microscope (Magnus). Pictures of the 
sections were taken by Samsung camera fixed with Magnus microscope and processed by 
using the software Photoshop. 
PHYSIO – CHEMICAL EVALUATION 82, 83-85 
Shade dried powdered plant material of seeds of Delonix regia (Boojer .Hook.) 
Raf,. was used for the determination of physio-chemical constants in accordance with 
WHO guidelines. 
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DETERMINATION OF ASH VALUES 
Ash values are helpful in determination the quality and purity of a crude drug in the 
powdered form. The residue remaining after incineration is the ash content of the drug, 
which simply represents inorganic salts, naturally occurring drug or adhering to it or 
deliberately added to it, as a form of adulteration. 
TOTAL ASH 
Total ash is designed to measure the total amount of material remaining after 
ignition. This includes both physiological ash which is derived from plant tissue itself and 
non – physiological ash which is the residue of the extraneous matter adhering to the plant 
surface. 
Procedure  
 Silica crucible was heated to red hot for 30 minutes and it was allowed to cool in 
desiccators. About 2gm of powdered sample was weighed accurately and evenly 
distributed in the crucible. Dried at 100 - 105°C for 1 hour and ignited to constant weight 
in a muffle furnace at 600 ± 25°C. The crucible was allowed to cool in desiccators. The 
percentage of ash with reference to the air dried substance was then calculated by the 
formula.  
%  ℎ 
 =
.   ℎ
.    
 × 100 
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Water soluble ash 
The ash was boiled for 5 minute with 25 ml of distilled water. The insoluble matter 
was then collected in an ash less filter paper. It was washed with hot water and ignited for 
15 minutes at a temperature not exceeding 450°C. The weight of insoluble matter was 
subtracted from the weight of the ash and the difference in weight represented the water 
soluble ash, the percentage of water soluble ash with reference to the air dried substances 
was calculated by the formula. 
%   ℎ 
 =
.   ℎ − .    ℎ
.    
 × 100 
Sulphated ash 
2 – 3 gm of air dried substance was ignited gently at first in a crucible, until the 
substance was thoroughly charred. Then the residue was cooled, moistened with 1ml of 
sulphuric acid, heated gently until the white fumes were no longer evolved and ignited at 
800 ± 25°C, until all the black particles were disappeared. The crucible was allowed to 
cool, a few drops of sulphuric acid was added and heated. Then it was ignited as before, 
cooled and weighed. The percentage of sulphated ash with reference to the air dried 
substance was then calculated. 
Determination of extractive values 
Extractive values are useful for the evaluation of phyto constituents especially 
when the constituents of a drug cannot be readily estimated by other means. Further these 
values indicate the nature of the active constituents present in a crude drug. 
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Determination of water soluble extractives 
5gm of the powder drug was weighed and macerated with 100ml of chloroform 
water (95ml distilled water and 5ml chloroform) in a closed flask for 24 hours. It was 
shaken frequently for six hours and allowed to stand for eighteen hours. It was filtered 
rapidly, taking precautions against loss of solvent and 25ml of the filtrate was evaporated 
to dryness in a tarred flat bottomed shallow dish. 2ml of alcohol was added to the residue 
and it was dried at 105°C for1 hour in the hot air oven and cooled in desiccators for 30 
minute and weighed. The process was repeated till a constant weight was obtained; the 
percentage of water soluble extractive value with reference to the air dried drug was 
calculated.                                     
  
 
 =
   
   
 × 100 
Determination of alcohol soluble extractive 
5gm of the powder was weighed and macerated with 100ml 90% ethanol in a 
closed flask for 24hours. It was shaken frequently for six hours and allowed to stand for 
eighteen hours. It was then filtered rapidly, taking precautions against loss of solvent and 
25ml of the filtrate was evaporated to dryness in a tarred flat bottomed shallow dish. It was 
dried at 105°C for 1 hour in a hot air oven. The dish was cooled in desiccators and 
weighed. The process was repeated till the constant weight was obtained. The percentage 
of alcohol soluble extractive value with reference to the air dried drug was calculated.                               
 ℎ  
 
 =
.   
.  ! 
 × 100 
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Determination of ether soluble extractive 
Transfer 5g of dried powdered drug to an extraction thimble and extract with 
solvent ether or petroleum ether Boiling Point 40-60ºc in a soxhlet for 6 hrs. The extract 
was filtered quantitatively into a tarred evaporating dish, evaporated and dried at 105ºc to 
constant weight. The percentage of ether soluble extractive value with reference to the air 
dried drug was calculated. 
Determination of moisture content (Loss on Drying) 
Specified quantity of the substances was taken in a previously ignited and cooled 
silica crucible and the substance was evenly distributed by gentle side wise shaking. The 
crucible with the contents was weighed accurately. The loaded crucible and the lid were 
placed in the drying chamber (105°C). The substance was heated for a specified period of 
time to a constant weight. The crucible was covered with the lid and allowed to cool in a 
desiccator at room temperature before weighing. Finally the crucible was weighed to 
calculate the loss on drying with reference to the air dried substance.  
% "  # =
"  $ℎ  ℎ 
.  ℎ 
 × 100 
Determination of foaming index 
1gm of the coarsely powdered drug was weighed and transferred to 500ml conical 
flask containing 100ml boiling water. The flask was maintained at temperature 80 - 90°C 
for about 30min. it was then cooled and filtered into a volumetric flask and sufficient water 
was added through the filtrate to make up the volume to 100ml. the decoction was poured 
into 10 stopper test tube (height 16cm, diameter 16mm) in successive portions of 1ml, 2ml, 
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3ml, 4ml up to 10ml and the volume of the liquid in each tube was adjusted with water to 
10ml and the volume of the liquid in each tube was adjusted with water to 10ml. the tube 
were stopper and shake in a length of the foam was measured. The results are assessed as 
follows. 
If the height of the foam in every tube is less than 1cm, the foaming index is less 
than100. If a height of 1cm is measured in any tube, the volume of the plant material 
decoction in the (a) is used to determine the index. If this tube is the first or second tube in 
a series, prepare an intermediate dilution in a similar manner to obtain a more precise 
result. 
If the height of the foam is more than 1cm in every tube, foaming index is over 
1000. In this case repeat the determination using a new series of dilution of the decoction 
in order to obtain a result. Calculate the foaming index using the following formula: 
Foaming index = 1000/a 
Where, a = the volume in ml of the decoction used for preparing the dilution in the tube 
where foaming to a height of 1cm is observed. 
Determination of swelling index 
The swelling index is the volume in ml occupied by the swelling of 1gm of plant 
material under specified conditions. A specified quantity of the plant material were 
previously reduced to the required fineness was accurately weighed and transferred into a 
25ml glass stoppered measuring cylinder. The internal diameter of the cylinder should be 
about 16mm, the length of the graduated portion about 125mm, marked in 0.2ml divisions 
from 0 to 25ml in an upward direction. Unless otherwise indicated in the test procedure, 
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add 25ml of water and shake the mixture thoroughly every 10min for 1hour, allowed to 
stand for 3 hours at room temperature. The volume in ml occupied by the plant material 
was measured including any sticky mucilage. Calculate the mean value of the individual 
determination, related to 1gm of plant material. 
QUALITATIVE AND QUANTITATIVE ANALYSIS OF HEAVY METALS AND 
INORGANIC ELEMENTS 86-89 
Plant minerals play a vital role in metabolism. Presence of elements vary with the 
soil, climate conditions etc. There are essential and non-essential elements which may be 
beneficial or harmful to living things. Non essential elements like lead, arsenic, cyanide, 
chromium, cadmium, aluminium, silver bring about toxic effects resulting in intoxification.  
QUALITATIVE ANALYSIS OF INORGANIC ELEMENTS AND HEAVY 
METALS  
To the ash of the drug material 50%v/v hydrochloric acid was added and kept for 1 
hour. It was filtered and the filtrate was used for the following tests. 
Aluminium: White gelatinous precipitate of aluminium hydroxide is formed on addition of 
ammonia solution. It is slightly soluble in excess of the reagent. The precipitate dissolves 
readily in strong acid and base, but after boiling it becomes insoluble. 
Arsenic: Arsenious salts in neutral solution react with solution of copper sulphate to form 
green precipitate (scheele’s green) which on boiling gives a red precipitate of cupric oxide.       
Borate: The mixture obtained by the addition of sulphuric acid and alcohol (95%) to a 
borate when ignited, burns with flame tinged with green. 
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Calcium: Solution of calcium salts, when treated with ammonium carbonate solution, 
yield a white precipitate after boiling and cooling the mixture (it is insoluble in ammonium 
chloride solution). 
Carbonate: Carbonate, when treated with dilute acid effervescence, liberating carbon 
dioxide which is colourless and produces a white precipitate in calcium hydroxide solution. 
Chlorides: Chlorides, when treated with silver nitrate solution, yield a white crude 
precipitate which is insoluble in nitric acid, but soluble after being well washed with water, 
in diluted ammonia, from which it is re precipitated by the addition of nitric acid. 
Copper: An excess of ammonia, added to a solution of a cupric salt, produces first a bluish 
precipitate and then a deep blue coloured solution. 
Iron: Solution of ferric salts, when treated with potassium ferrocyanide solution, yields an 
intense blue precipitate which is insoluble in dilute Hcl. 
Lead: Strong solution of lead salts, when treated with Hcl, yield a white precipitate. Which 
is soluble in boiling water and is re deposited as crystals when the solution is cooled. 
Magnesium: Solution of magnesium salts, when treated with ammonium carbonate 
solution and boiled, yield a white precipitate, but yield no precipitate in the presence of 
ammonium chloride solution. 
Mercury: Solution of mercury salts, when treated with sodium hydroxide solution, yields 
a yellow precipitate. 
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Nitrate: With solution of ferrous sulphate no brown colour was observed but if sulphuric 
acid is added (slow from the side of the test tube), a brown colour is produced at the 
junction of two liquids, indicating the presence of nitrates. 
Phosphate: Solution of phosphate when treated with silver nitrate with dilute ammonia 
solution and in dilute nitric acid yield yellow precipitate of normal silver ortho phosphate 
(distinction from meta and pyrophosphate) solution. 
Potassium: Moderately strong potassium salts, which have been previously ignited to 
remove ammonium salts, when treated with perchloric acid (60%) yield a white crystalline 
precipitate.  
Silver: Solution of silver salts, when treated with potassium iodide solution yield a cream 
coloured precipitate which is insoluble in dilute ammonia solution and in nitric acid. 
Sulphates: Solution of sulphates, when treated with lead acetate solution yields a white 
precipitate which is insoluble in ammonium acetate solution and in sodium hydroxide. 
QUANTITATIVE ESTIMATION OF INORGANIC ELEMENTS 
Inductive coupled plasma-Optical emission spectroscopy (ICP-OES) 
It is an excellent multi-element technique with relatively good sensitivity and 
selectivity when configured correctly. This technique utilizes the plasma as an ion source 
or light emission source are capable of producing values. 
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QUANTITATIVE ANALYSIS OF HEAVY METALS 
Instrumentation parameters: 
Instrument name: Inductive coupled plasma-Optical emission spectroscopy 
Instrument Model: PE Optima 5300DV ICP-OES; Optical system Dual view-axial or 
radial 
Detector system:  Charge coupled detector, (UV-Visible detector which is maintaining at -
40ºC) to detect the intensity of the emission line. 
Light source (Torch):  Positioned horizontally in the sample compartment along the 
central axis of the spectrometer optics. Changing from axial to radial viewing is a simple 
software command and is accomplished by computer control of a mirror located in the 
optical path. The torch assembly of this system comprises of two concentric quartz tubes. 
Standard alumina injector: 2.0mm inner diameter. 
Spray chamber: Scott type 
Nebulizer: Cross flow gem tip. 
Preparation of sample by acid digestion method:  
50mg of powder was treated with acid mixture of sulphuric acid: water in the ratio 
of 4:1in the Kjeldahl flask and heated continuously till the solution is colourless. The 
sample mixture was then transferred in a 25ml volumetric flask and made up to the volume 
with distilled water. Blank solution was prepared as above without sample. 
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The standards of Arsenic, Lead, Mercury and Cadmium were prepared as per the protocol 
and the calibration curve was developed for each of them. 
Detection: 
Samples were analyzed for the detection and quantification of the aluminium, 
calcium, chloride, borate, silver, copper, potassium, magnesium, iron by Inductively 
Coupled Plasma Emission Spectrometry. 
PHYTOCHEMICAL STUDIES 
Phytochemical evaluation is used to determine the nature of phyto constituents 
present in the plant by using suitable chemical tests. It is essential to study the 
pharmacological activities of the plant. It can be done by confirmation with different 
chromatographic techniques like TLC and HPTLC. Therefore a complete investigation is 
required to characterize the Phytoconstituents qualitatively and quantitatively. 
Preparation of Extracts90 
Extraction is the preliminary step involved in the phytochemical studies. It brings 
out the metabolites into the extracting solvent depends upon its polarity. 
Extraction 
The first step was the preparation of successive solvent extracts. The dried coarsely 
powdered sample of Delonix regia (Hook.) Raf. Seed (500gm) was first extracted with 
Hexane in Soxhlet apparatus and then with solvents of increasing polarity like Ethyl 
acetate, ethanol (at 60 - 70ºC) and water. Each extract was concentrated using rotary 
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vacuum evaporator. The percentage yield, colour and consistency of these extracts were 
recorded and preceded for further detailed phyto chemical and pharmacological screening. 
PRELIMINARY PHYTOCHEMICAL SCREENING 91-103 
The chemical tests for various Phyto constituents in the dried powder and extracts 
of seeds of Delonix regia (Hook.) Raf., were carried out as described below and the results 
were recorded. 
Detection of Alkaloids: Small quantity of the extract was treated with few drops of diluted 
hydrochloric acid and filtered. The filtrate was used for the followings, 
a. Mayer’s reagent (Potassium mercuric iodide solution) 
Alkaloids give cream colour precipitate with mayer’s reagent. 
b. Dragendorff’s reagent (Potassium bismuth iodide solution) 
Alkaloids give reddish brown precipitate with Dragendorff’s reagent. 
c. Hager’s reagent (Saturated solution of picric acid) 
Alkaloids give yellow coloured precipitates with Hager’s reagent. 
d. Wagner’s reagent (Solution of iodine in potassium iodide) 
Alkaloids give reddish brown precipitate with wagner’s reagent. 
Detection of Proteins 
Biuret test: The sample was treated with 5-8 drops of 10% w/w copper sulphate 
solution, violet colour is formed. 
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Detection of Flavonoids 
a. Shinoda’s test: Small quantity was dissolved in alcohol to these pieces to 
magnesium followed by concentrated hydrochloric acid were added drop wise 
and heated. Appearance of magenta colour shows the presence of flavonoids. 
b. With aqueous sodium hydroxide solution: Small quantity of the extract was 
dissolved in aqueous sodium hydroxide and appearance of yellow colour 
indicates the presence of flavonoids. 
c. Zinc hydrochloride test: Small quantity the extract was mixed a mixture of 
zinc dust and conc. Hcl acid. It gives red colour after a few minutes. 
Detection of Tannins 
a. Lead acetate test: The test solution was mixed with basic lead acetate solution 
and examined for formation of a white precipitate. 
b. Ferric chloride test: A few drops of 5% aqueous ferric chloride solution was 
added to 2ml of an aqueous extract of the drug and examined for the appearance 
of bluish black colour. 
Detection of fixed oils and fats 
a. Spot test: Small quantities of extracts were pressed between two filter papers. 
An oily stain on filter paper indicates the presence of fixed oils and fats. 
b. Saponification test: Few drops of 0.5 % alcoholic potassium hydroxide were 
added to a small quantity of various extracts along with a drop of 
phenolphthalein. The mixture was heated on the water bath for 1-2 hr. 
Formation of soap with the alkali indicates the presence of fixed oils and fats. 
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Detection of Glycosides 
a. Borntrager’s test: The powdered material was boiled with 1ml of sulphuric 
acid in a test tube for five minutes. Filtered while hot, cooled and shaken with 
equal volume of chloroform. The lower layer of solvent was separated and 
shaken with half of its volume of dilute ammonia. A rose pink to red colour is 
produced in the ammoniacal layer. 
b. Modified Borntrager’s test: The test material was boiled with 2ml of the 
dilute sulphuric acid. This was treated with 2ml of 5% aqueous ferric chloride 
solution (freshly prepared) for 5 minutes, and shaken with equal volume of 
chloroform. The lower layer of solvent was separated and shaken with half of 
its volume of dilute ammonia. A rose pink to red colour is produced in the 
ammoniacal layer. 
Detection of Steroids and Triterpenoids 
a. Libermann Burchards test: The powdered drug was treated with few drops of 
acetic anhydride, boiled and cooled. Conc. sulphuric acid was added from the 
sides of the test tube; brown ring is formed at the junction of two layers and 
upper layer turns green which shows presence of steroids and formation of deep 
red colour indicates presence of tri terpenoids. 
b. Salkowski test: The extract was treated with few drops of concentrated 
sulphuric acid, red colour at lower layer indicates presence of steroids and 
formation of yellow coloured lower layer indicates presence of tri terpenoids. 
c. Nollers test: The extract was warmed with tin and thionyl chloride. Pink 
colouration indicates the presence of triterpenoids.    
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d. Sulfur powder test: The extract added with small amount of sulfur powder, it 
sinks at the bottom.  
Detection of Carbohydrates 
a. Molisch’s test: To the test solution few drops of alcoholic solution of α napthol 
and few drops of conc. sulphuric acid were added through the sides of test tube, 
purple to violet colour ring appears at junction. 
b. Fehling’s test: The test solution was mixed with Fehling’s I and II and heated 
and examined for the appearance of red coloration for the presence of sugar. 
Detection of Saponins: A drop of sodium bicarbonate solution was added to the sample 
and the mixture was shaken vigorously and left for 3 minutes. Development of any honey 
comb like froth was examined. 
FLUORESCENCE ANALYSIS 104-106  
Many crude drug show the Fluorescence when the sample is exposed to UV 
radiation. Evaluation of crude drugs based on fluorescence in day light is not much 
used, as it is usually unreliable due to the weakness of the fluorescent effect. 
Fluorescent lamps are fitted with suitable filter, which eliminate visible radiation 
from the lamp and transmits UV radiation of definite wavelength. Several crude 
drugs show characteristic fluorescence useful for their evaluation. 
QUANTITATIVE ESTIMATION OF PHYTOCONSTITUENTS 
TOTAL SAPONNIN CONTENT107 
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20 gm of the powder of seeds was put into a conical flask and 100ml of 20% 
aqueous ethanol were added. The samples were heated over a hot water bath for 4 hrs with 
continuous stirring at about 55ºC. The mixture was filtered and the residue re-extracted 
with another 200ml of 20% of ethanol. The combined extracts were reduced to 40 ml over 
water bath at about 90ºC. The concentrate was transferred into a 250 ml separating funnel 
and 20ml diethyl ether was added and shaken vigorously. The aqueous layer was recovered 
while the ether layer was discarded. The purification process was repeated.60 ml of n-
butanol was added. The combined n-butanol extracts were washed twice with 10ml of 
aqueous sodium chloride. The remaining solution was heated in a water bath. After 
evaporation the samples were dried in the oven to a constant weight. The saponins content 
was calculated as percentage. 
TOTAL FLAVONOID CONTENT 108-109 
Total flavonoid content was measured by the aluminium chloride colorimetric 
assay. An aliquot (1ml) of extracts or standard solutions of quercetin (20, 40, 60, 80 and 
100µg/ml) was added to 10 ml volumetric flask containing 4 ml of distilled water. To the 
flask was added 0.30 ml of 5% NaNO2, after 5min 0.3 ml of 10 % AlCl3 was added. After 
5min, 2 ml of 1M NaOH was added and the volume was made up to 10 ml with distilled 
water. The solution was mixed and absorbance was measured against the blank at 510 nm. 
The total flavonoid content was expressed as mg quercetin equivalents (QE). 
CHROMATOGRAPHY109-110  
Chromatography methods are important analytical tool in the separation, 
identification and estimation of components present in the plant. 
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THIN LAYER CHROMATOGRAPHY 
Principle 
Thin layer chromatography is a technique used for the separation, identification and 
estimation of single or mixture of components present in the various extracts. It is reliable 
technique in which solute undergoes distribution between two phases, stationary and 
mobile phase. The separation is mainly based on the differential migration that occurs 
when a solvent flows along the thin layer of stationary phase. This may be achieved by 
partition and adsorption depending on stationary phase used. 
 TLC Plate Preparation 
The plates were prepared using Stahl TLC spreader. 40gm of silica gel G was 
mixed with 85ml of water to prepare homogenous suspension and poured in the spreader. 
0.25mm thickness of plates was prepared, air dried until the transparency of the layer 
disappeared, then dried at 110°C for 30 minutes and kept in desiccators. 
Selection of mobile phase 
Solvent mixture was selected on the basis of the phyto constituents present in each 
extract. Factors such as nature of components, stationary phase, mobile phase, polarity, 
influence the rate of separation of constituents. From the vast analysis, best solvent was 
selected which showed good separation with maximum number of components. 
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The Retardation Factor (Rf) is calculated using following formula, 
%& =
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HPTLC- FINGERPRINT PROFILE 
HPTLC is one of the versatile chromatographic method which helps in the 
identification of compounds and thereby authentication of purity of herbal drugs. The time 
required in this method for the demonstration of most of the characteristic constituents of a 
drug is very quick and short. In addition to qualitative detection, HPTLC also provides 
semi- quantitative information on major active constituents of a drug, thus enabling an 
assessment of drug quality. 
Instrument Conditions 
Sample used : Ethanol Extract 
Instrument    : CAMAG HPTLC 
HPTLC Applicator   : CAMAG LINOMAT IV 
HPTLC Scanner   : CAMAG TLC SCANNER II 
Sample dilution   : 100mg of sample extracted with 1ml of Ethanol 
Volume of injection   : 20µl 
Mobile phase : Hexane: Ethyl acetate: Chloroform: Methanol: Formic acid  
  (2:3:5:0.5:0.5) 
Lambda max  :  400 - 800nm 
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Lamp   : Tungsten 
Stationary phase :  TLC Aluminium coated silica gel 60 F254 (Merck) 
Equipment: A Camag HPTLC system equipped with a sample applicator 
Linomat IV, Twin trough plate development chamber, TLC 
Scanner II. 
Chromatographic conditions 
The estimation has been done using the following chromatographic conditions. 
Chromatography was performed on a 12 × 3 cm (H x W) pre-activated HPTLC silicagel 60 
F254 plate. Samples were applied to the plate as 6mm wide band with an automatic TLC 
applicator Linomat IV with nitrogen flow (CAMAG, Switzerland), 8mm from the bottom. 
Densitometric scanning was performed on CAMAG scanner II. The plates were pre-
washed with solvent ethyl acetate. 
HPTLC serves as a convenient tool for finding the distribution pattern of phyto 
constituents which is unique to each plant. The fingerprint obtained is suitable for 
monitoring the identity and purity of drugs and for detecting adulteration and substitution. 
HPTLC technique is helpful in order to check the identity, purity and standardize the 
quantity of active principles present in the herbal extract. 
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PHARMACOLOGICAL STUDIES 
STUDIES SELECTION OF ACTIVE EXTRACT 
IN VITRO ANTI - OXIDANT ACTIVITY36 
DPPH assay: (2, 2-diphenyl-1-picrylhydrazyl) 
0.1 ml of the chloroform extract was taken in test tubes. 6 ml of DPPH (diphenyl 
picryl hydrazyl) solution was added and the tubes kept in dark for one hour. The colour 
was read at 517 nm. The difference in the Optical density of DPPH solution and DPPH 
solution + sample was calculated. The decrease in OD with sample addition is used for 
calculation of the antioxidant activity. The activity was compared with BHT (butylated 
hydroxyl toluene) standard. Free radical scavenging activity was expressed as the 
inhibition percentage calculated using the formula 
%  !
  
# 
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 × 100 
IN VITRO ANTI – DIABETIC ACTIVITY36,111 
α-amylase inhibition assay 
In vitro amylase inhibition was studied by the method of Bernfeld. In brief, 100µl 
of the test extract was allowed to react with 200µl of α-amylase enzyme (Hi median 
Rm638) and 100µl of 2mM of phosphate buffer (PH – 6.9). After 20 minute incubation, 
100µ of 1% starch solution was added. The sample was performed for the controls where 
200µl of the enzyme was replaced by buffer. After incubation for 5minutes, 500µl of 
dinitrosalicylic acid reagent was added to both control and test. They were kept in boiling 
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water bath for 5minutes. The absorbance was recorded at 540nm using spectrometer and 
the percentage inhibition of α-amylase enzyme was calculated using the formula 
(ℎ (%)  =  
    −    
   
 × 100 
Suitable reagent blank and inhibitor controls were simultaneously carried out. 
ACUTE ORAL TOXICITY STUDY (UP AND DOWN METHOD) OECD 425 
GUIDLINE FOR THE TESTING OF CHEMICALS 112 
 The organization of economic co – operation and development (OECD) guideline 
425 was followed the acute oral toxic up and down method is a stepwise procedure which 
5 rats of single sex per step (one animal per step). Depending upon the mortality and 
morbidity status of the animal, on average of 2 to 4 steps may be necessary to allow 
judgement on the acute oral toxicity of the substance. This procedure results in the use of 
minimal number of animal while allowing for acceptable data based scientific conclusion. 
 Literature review showed that the Delonix regia is not toxic till the dose level of 
2000mg/kg. Hence a starting dose level of 2000mg/kg of polysaccharides of Delonix regia 
seeds was used. After oral administration, animals were observed at an hourly basis for the 
first 4 hour and periodically for 24 hour to assess the general behaviour for 72 hours toxic 
symptoms and mortality of the animal for 28 days.  
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IN VIVO ANTI DIABETIC ACTIVITY 36, 114 - 118 
EVALUATION OF ANTI DIABETIC ACTIVITY STREPTOZOTOCIN INDUCED 
DIABETES  
EXPERIMENTAL DESIGN 
Plant extracts 
i. Ethanol extract of Delonix regia (Hook.) Raf., seeds. 
Chemicals  
ii. Streptozotocin was obtained from Lab chemicals, India. 
iii. Glibenclamide was obtained from Aventis pharmaceuticals, Goa. 
Experimental animals 
Healthy wistar albino male rats (weighing 170-230mg) were produced from Madras 
Medical College Animal house. The entire process was approved by the Institutional 
Animal Ethical Committee which is certified by the Committee for the purpose of control 
and supervision of experiments on animals, India (CPCSEA). 12/243/CPCSEA. 
 The animals were kept clean and dry polycarbonate cages and maintained in a well 
ventilated animal house with 12 hour light / 12 hour dark cycle. The animals were with 
standard pellet diet and water was given adlibitum. For experimental purpose the animals 
were kept fasting overnight but allowed for access to water. 
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EXPERIMENTAL INDUCTION OF NON – INSULIN DEPENDENT DIABETES 
MELLITUS (NIDDM) 
The rats were injected intraperitoneally with Streptozotocin dissolved in citrate 
buffer (PH 4.5) at a dose of 60mg/kg body weight. Hyperglycaemia was confirmed by the 
elevated blood glucose level in plasma, determine at the end of 0 hr, 1hr, 3hr, 5hr, 7hr, 
24hr (Acute study Table 22)and then 7 day after injection. Rats with blood glucose level 
above 126mg/dl were selected for the study. Samples are analysed for blood glucose 
content by Glucometer.    
EXPERIMENTAL DESIGN FOR STREPTOZOTOCIN INDUCED 
HYPERGLYCEMIC STUDIES 
Animals were randomly divided into 5 group of 6 rats (n = 6) 
Table 6. The animals received treatments 
S. No Group 
Name of the 
drug 
Dose No of animals 
Duration of 
dosage (days) 
1 Group – 1 Normal control Saline 6 28 
2 Group – 2 
Diabetic control 
(0.9% v/v saline) 
2ml p.o 6 28 
3 Group – 3 
Standard 
(glibenclamide) 
3mg/kg 
p.o 
6 28 
4 Group – 4 Test drug – I 
200mg/kg 
p.o 
6 28 
5 Group – 5 Test drug – II 
400mg/kg 
p.o 
6 28 
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In an earlier study, the experimental animals were fasted for 18 hours and the 
Blood glucose level (BGL) was monitored using a Glucometer after Streptozotocin 
Injection. Blood samples were collected by tail clipping method.  Rats with blood glucose 
level of greater than 250mg/dl were considered diabetic and were selected for study 
(WHO, 1985) Rats were divided randomly into 5 Groups of 6 rats per group for screening. 
Streptozotocin monohydrate 60mg/kg body weight was dissolved in 0.9% v/v Cold 
normal saline and injected intraperitoneally to 18 hours fasted rats (24 no’s,) group II-IV in 
order to induce hyperglycaemia in experimental Wistar rats (170–230 g body Weight (b/w) 
and the six control rats (group-I) received equal volume of 0.9% v/v Cold normal saline 
injected intraperitoneally.  
BIOCHEMICAL ANALYSIS  
ORAL GLUCOSE TOLERANCE TEST (OGTT) 
Glucose 2g/kg fed 30 minutes prior to the administration of extracts. Blood 
withdrawn from retro orbital sinus at 30, 60 and 120 minutes and 1st, 2nd and 3rd week 
(Chronic study Table 23) then  the plasma obtained after centrifugation at 3000 rpm was 
estimated for fasting plasma glucose levels using GOD – POD kit. Other parameters like 
serum total protein, albumin, creatinine, urea, total bilurubin, SGOT, SGPT, ALP and 
Total cholesterol (TC), serum triglycerides (TG), low density lipoprotein (LDL), high 
density lipoprotein (HDL), very low density lipoprotein (VLDL) was estimated. 
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HYPOLIPIDEMIC ACTIVITY 
Determination of lipid profile and lipoproteins 
 At the end of the study, blood sample were collected from retro orbital plexus into 
universal non – heparinised tubes. Allow it to clot in air, which was later centrifuged at 
5000 rpm for 5minuts and serum separated to precede analysis. Initial and final body 
weights were analysed. 
 Serum levels of the following tests were determined by auto analyser in the 
biochemical laboratory, Madras Medical College, Chennai. Parameters like Total 
Cholesterol (TC), Serum Triglycerides (TG), Low Density Lipoprotein (LDL), High 
Density Lipoprotein (HDL), Very Low Density Lipoprotein (VLDL) was estimated. 
 Serum VLDL  
The value of VLDL was calculated as follows 
+,-, ./012342501 =  
657819.257:23
;
 
Serum LDL 
The value of LDL was calculated as follows 
                LDL cholesterol = Total cholesterol – (HDL cholesterol + VLDL cholesterol) 
COLLECTION OF BLOOD AND ORGANS112,114,118  
The treatment is carried up to 28 days and on 1st, 7th, 14th and 21st days 0.5 ml of 
blood was collected from lateral tail vein using lance or butterfly needle and blood glucose 
level was checked by using a Glucometer. After 28 days the blood was collected and used 
to determine haematological parameters. The test animals were anesthetized with ketamine 
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at the dose of 10 mg/kg and sacrificed. Pancreas was isolated and used for 
histopathological studies. 
HISTOPATHOLOGICAL STUDY112,114,118 
For histological examinations, small pieces of pancreas were fixed In Bouin's 
Solution for 24h dehydrated through graded concentration of ethanol, embedded in 
Paraffin wax, sectioned at 5µm thicknesses and stained with Mayer's haematoxylin and 
Eosin and observed under light microscope. 
STATISTICAL ANALYSIS 
Results were expressed as Mean ± S.E.M. The data was analyzed using One 
Way of Variable (ANOVA) followed by Dennett’s test. P-value <0.05 considered as 
significant. 
ISOLATION AND CHARACTERISATION OF PHYTOCONSTITUENTS BY 
COLUMN CHROMATOGRAPHY 100-103  
Column chromatography is an isolation technique in which phytoconstituents are 
being eluted by adsorption.  The principle involved in this separation of constituents is 
adsorption at the interface between solid-liquid. The component must have various degree 
of affinity towards adsorbent and also reversible interaction to achieve successful 
separation. No two compounds are alike in above respect. Low affinity compound will 
elute first. Adsorbent used is silica gel. 
 Ethanolic extract of Delonix regia (Hook.) Raf., seeds was found to posses 
maximum phytoconstituents with anti diabetic activity. An attempt was made to 
fractionate the ethanolic extract by column chromatography. 
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COLUMN CHROMATOGRAPHY 
 Type of extract : Ethanolic extract 
 Method  : Dry packing method 
 Packing material : Silica gel G70-325 
PROCEDURE 
The ethanolic extract was subjected to Silica gel column chromatography for 
isolation of phytoconstituents.  
An appropriate column sized 2.5 cm diameter and 60 cm length was used. It was 
washed with water and rinsed with acetone and dried completely. Little of pure cotton was 
placed at the bottom of column with help of a big glass rod. Solvent Hexane was poured in 
to the column 3/4th level. Before packing, ethanolic extract 10 gm was diluted with same 
solvent and thoroughly mixed with 30 g of graded silica gel.  
It was constantly mixed until it became free flow. When it reached at defined state 
it was slowly poured in to the column containing hexane solvent with slight movement of 
stirring by glass rod to avoid clogging. Once it got settled, little cotton was placed on top 
of silica gel extract mixture pack to get neat column pack.  
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The knob at bottom was slowly opened to release the solvent. The elute was done 
using hexane, followed by hexane
Each fraction were collected and analysed quantitatively. Similar fractions were mixed
together, allowed to evaporate to remove solvent. 
 
Materials and 
 
Fig .15 Method Column chromatography 
-ethyl acetate mixture and ethyl acetate
 
 
Ethanolic extract of Delonix regia10g
Column chromatography 
silica gel, Hexane, ethyl 
acetate, ethanol gradient 
elution
Fraction 1-33
narrow band  seven spot 
observed
methods 
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-ethanol mixture. 
 
Materials and methods 
 
Dept. Of Pharmacognosy, MMC. Page 69 
 
THIN LAYER CHROMATOGRAPHY (TLC) 
As soon as the fraction eluted, it was analyzed by using readymade TLC plate with 
suitable mobile solvent according to the polarity of elute.  
SOLVENT SYSTEM 
Ethanol: Ethyl acetate in 3.5: 2.5  
OBSERVATION 
The developed chromatogram was observed under UV, Fluorescence and also 
derivatised using detecting agent. 
SPECTRLA ANALYSIS 
 Purified single isolated compound was taken to determine the structural by 
instrumental spectral analysis such as 
a. IR spectroscopy 
b. GC – MS spectroscopy 
a. IR spectroscopy 
    IR spectrum is considered as vibrational – rotational spectra. KBR pellet 
technique was used for solid compound, for liquid compound Nujol mull method was 
followed. It is very helpful record which would give information about functional group 
present in the organic compounds. Mechanism of bond stretching and bending is happened 
when electromagnetic radiation ranging from 500cm-1 to 4000cm1 passed through sample. 
Instrument used was ABD BOWMAN spectrometer. 
b. GC-MS 
It is combined technique, used for molecular weight determination. Gas 
chromatography and mass spectroscopy combined to form GC – MS.   
  
 
 
 
 
RESULTS AND 
DISCUSSION 
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8. RESULT AND DISCUSSION 
PHARMACOGNOSTICAL STUDIES 
Organoleptic characters: 
Nature  : Soft and glossy 
Colour           : Brown 
Odour          : Odourless 
Taste              : Tasteless 
Morphological characters: 
Colour :  Greenish brown 
Appearance   :  Hard seed coat 
Shape         :  Oblong 
Seed length :  2.3 – 2.6cm 
Seed width     : 0.6 – 0.8cm 
Surface      : Smooth and shine 
Thickness     : 1.2 – 1.8mm 
Results and discussion 
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                                Fig .16
 
                Fig .17 Delonix regia
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 Delonix regia ( Boojer .Hook.) Raf. seed pods
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Microscopical features 
Transverse section of seed 
 The seed coat is 1.2mm thick. It contains of outer epidermal layer followed by a 
thin zone of 2 or 3 years of parenchyma cells. 
 The middle part of the seed coat consists of vertical layer elongated, compact 
sclereids. 
 The sclerotic zone merges with a lignified inner seed coat include 3 or 4 layers of 
circular, compact parenchyma zone. 
 The outer epidermal sub epidermal layers are 90µm thick. The outer sclerotic seed 
coat is 150µm thick. 
 The inner sclerotic seed coat is 700µm thick. The inner most parenchymatous zone 
is 140µm thick. 
 When viewed under polarized light the middle part of the seed coat which include 
outer and inner sclerotic layer appear bright indicating the presence of lignified 
walls. 
 The cells of the inner and outer seed coat are vertically elongated narrow 
cylindrical cells. They have very narrow cell lumen. 
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MICROSCOPIC FEATURES OF THE SEEDS
TRANSVERSE SECTION OF THE SEED
                     
 
Fig 19. Seed Coat entire view
EP – Epidermis  
OSC – Outer seed coat 
ISC – Inner seed coat 
Pa - Parenchyma 
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    Fig 19. Seed Coat entire view 
 
 
\\\\ 
 
Page 74 
  
Results and discussion 
 
Dept. Of Pharmacognosy, MMC. Page 75 
 
 
 
 
 
 
                               Fig 20. Middle sclerotic zone in transverse section                                                     
                            Fig 20. Middle sclerotic zone in transverse section  
OSC – Outer seed coat 
ISC – Inner seed coat 
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                Fig 21. Seed coat showing inner seed coat and inner parenchyma zone
 
Fig 21. Seed coat showing inner seed coat and inner parenchyma zone
OSC – Outer seed coat 
ISC – Inner seed coat 
Pa – Parenchyma 
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Fig 22. Inner sclerostesta enlarged  
ISC –Iuter seed coat        
POWDER MICROSCOPY
The powder preparation of the seed includes the following elements
 Thick pieces of sclerostesta are often visible in the powder. These pieces consist of 
compact vertically elongated columnar sclereids which are compactly arranged.
 When the columnar sclereids were separated the outer ends of the sclereids consists 
of thin long fibrils
fibril portion is 100µ m long.
 Sclereids Circular branchy sclereids are often seen in the powder. They have very 
thick lignified walls and circular, wide lumen 
µm in size. 
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Fig 22. Inner sclerostesta enlarged   
 
         
 
. The columnar sclereids are 250 µm long and 20 µm thick. The 
 
Fig. 22a. The sclereids are 200X120 
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 Sclerenchyma cells Small fragments of thick walled sclerenchyma cells are seen in 
Fig. 22c. The cells are elongated and rectangular with wide lumen .The cells are 
50x 100µm in size. 
 
a                                                  b                                           c 
                                   a). Palisade epidermis, b).Parenchyma c). Sclerenchyma 
 
           d                                      e                                    f                                     g 
d). Sclerotic seed coat, e). Isolated bearer cells, f). Trichomes, g). Calcium oxalate 
crystals 
Fig 23. Powder microscopical features 
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HISTOCHEMICAL COLOUR REACTION 
Table 7. Histochemical colour reactions of seeds of  Delonix regia (Boojer .Hook.) Raf. 
S. No Chemicals Test for Nature of 
change Histology 
Degree of 
change 
1 Phloroglucinol + Hcl Lignin 
No pink 
colour 
Middle seed 
coat _ 
2 N/50 Iodine 
solution Starch 
No blue 
colour 
Endosperm & 
embryo _ 
3 Dil. Ferric 
chloride Tannin 
No bluish 
black colour 
Epidermal 
layer & inner 
seed coat 
_ 
4 Picric acid Protein No yellow 
colour Endosperm _ 
5 Dragendroff’s 
reagent Alkaloid 
No orange 
colour 
Inner seed 
coat _ 
Note: (-) Indicates the absence 
PHYSIO – CHEMICAL CONSTANTS 
Table 8. The Physicochemical analysis of the seeds of Delonix regia (Boojer .Hook.) Raf. 
Parameters Results (%W/W) 
Ash values 
Total ash 
Sulphated ash 
Water soluble ash 
Acid insoluble ash 
2.53±0.005 
15.0±0.20 
1.1±0.01 
0.7±0.01 
Loss on drying 6.5±0.15 
Extractive values 
Water soluble extractive 
Alcohol soluble extractive 
Ether soluble extractive 
Non – volatile ether soluble 
extractive 
11.0±0.1 
5.0±0.2 
2.9±0.05 
3.6±0.05 
Other parameters Foaming index Swelling index 
<100 
NIL 
Values are expressed as mean ±SD, n= 3 
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INORGANIC ELEMENTS AND HEAVY METAL ANALYSIS 
Table 9. Qualitative analysis of inorganic elements of Delonix regia ( Boojer .Hook.) 
S. No Inorganic elements Observations 
1 Aluminium + 
2 Chloride + 
3 Copper + 
4 Calcium + 
5 Iron + 
6 Borate + 
7 Potassium + 
8 Silver + 
9 Phosphate - 
10 Nitrate - 
11 Sulphate - 
+indicates presence, -indicates absence 
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QUANTITATIVE ESTIMATION OF INORGANIC ELEMENTS 
Table. 10. Quantitative analysis of inorganic elements of Delonix regia  
(Boojer .Hook.) 
S. No Inorganic elements Total amount (%W/W) 
1 Aluminium 0.028 
2 Chloride 0.052 
3 Copper 0.009 
4 Calcium 0.010 
5 Iron 0.028 
6 Borate 0.005 
7 Potassium 0.020 
8 Silver 0.007 
 
 
QUANTITATIVE ESTIMATION OF HEAVY METALS BY ICP OES METHOD 
The quantification of the individual heavy metals was analyzed for the powdered 
mixture of Delonix regia ( Boojer .Hook.) Raf., by ICP-OES technique the following 
metals like arsenic, lead, cadmium were detected and quantified, results are given in the 
following table. 
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Table 11. Quantitative estimation of Heavy metals for Delonix regia ( Boojer .Hook.) 
Raf., 
S. No Results Specification as per WHO guidelines 
1 Mercury Not detected Not more than 0.5ppm 
2 Arsenic 0.053 Not more than 5.0ppm 
3 Lead 0.042 Not more than 10ppm 
4 Cadmium 0.002 Not more than 0.3ppm 
 
The above observation showed that the material is within the limits as per WHO standard 
and it is safe to consume internally. 
PHYTOCHEMICAL STUDIES 
Table 12. Percentage yield of successive solvent extraction of various extracts of seeds 
of Delonix regia (Boojer .Hook.) 
S. No Extract Method  of Extraction 
Physical 
Nature Colour 
Yield 
(%W/W) 
1 Hexane 
 
Successive solvent 
extraction 
Semi-solid Green 0.6 
2 Ethyl acetate Sticky Brownish green 1.3 
3 Ethanol Semi-solid Green 4.6 
4 Aqueous Solid Brown 5.7 
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QUALITATIVE PHYTOCHEMICAL ANALYSIS 
Table 13. Qualitative Phytochemical analysis Delonix regia ( Boojer .Hook.) Raf., 
Phytoconstituents Powder Hexane 
extract 
Ethylacetate 
extract 
Ethanol 
extract 
Aqueous 
extract 
Alkaloids - - - - - 
Saponins + + - + + 
Glycoside - - - - - 
Carbohydrates - - + + - 
Tannins and phenolic 
compounds - - - - - 
Flavonoids + - + + - 
Phytosterols + + - + - 
Proteins and 
aminoacids - - - - - 
Triterpenoids + + - + - 
Fixed oils and fats + + - + - 
Gums and mucilage - - - - - 
Note: (+) indicates presence, (-) indicates absence. 
1.1.1. QUANTITATIVE ESTMATION OF PHYTOCONSTITUENTS 
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The Delonix regia ( Boojer .Hook.) was found to contain various phytochemical 
constituents and hence it is desirable to quantify few of them in order to establish a 
standard to maintain its quality. Among them the estimation of total Saponins and 
Flavonoids content in the ethanol extract were decided to be taken as parameters. Samples 
were drawn from three random samples of Delonix regia ( Boojer .Hook.) and the total 
Saponins and Flavonoids content present in them were estimated. 
Table 14. Quantitative Estimation of Phytoconstituents 
S. No Parameters Values (µg/ml) 
1 Total saponins 5.24 ±0.15 
2 Total flavonoids 7.86 ± 0.65 
FLUORESCENCE ANALYSIS 
Table 15. Fluorescence characteristic of powdered samples of Delonix regia  
( Boojer .Hook.) at short UV and long UV. 
Treatment Day light UV light 254nm 365nm 
Powder as such Brownish green Dark brown Pale brown 
Powder + water Pale brown Dark brown Pale brown 
Powder + NaOH Brownish green Dark green Pale brown 
Powder + Hcl Dark green Brownish green Pale brown 
Powder + Acetic acid Pale brown Dark brown Pale brown 
Powder + Alc.NaOH Brownish green Dark green Pale brown 
Powder + Picric acid Brownish yellow Brownish yellow Yellowish brown 
Powder + Sulphuric 
acid Pale brown Brownish green Pale brown 
Powder + Nitric acid Brownish green Dark brown Pale brown 
Powder + Iodine Dark brown Dark brown Dark brown 
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Table 16. Fluorescence analysis of various extracts of Delonix regia ( Boojer .Hook.) 
Treatment Day light 
UV light 
Short UV(254nm) Long UV (365nm) 
Hexane extract Dark greenish brown Dark brown Dark brownish 
Ethyl acetate 
extract Dark brown 
Dark brownish 
green Reddish brown 
Ethanol extract Dark brown Dark brown Reddish brown 
Aqueous extract Dark brown Dark brown Dark greenish brown 
 
 
THIN LAYER CHROMATOGRAPHY OF EXTRACTS 
 
Table 17. Thin layer chromatography of various extract of Delonix regia ( Boojer 
.Hook.)  
S. No Extracts Solvent system No of spots Rf  value 
1 Hexane 
Ethyl acetate: 
Ethanol: Water 
100:13.5:10 
1 
0.38 
0.53 
0.60 
2 Ethyl acetate 
Ethyl acetate: 
Ethanol: Water 
100:13.5:10 
3 0.55 
3 Ethanol 
Ethyl acetate: 
Ethanol: Water 
100:13.5:10 
2 0.59 0.80 
4 Aqueous 
Ethyl acetate: 
Ethanol: Water 
100:13.5:10 
- - 
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                          a)                               b)                               c)                               d)  
a)Hexane, b)Ethyl acetate, c)Ethanol, d)Aqueous 
Fig 24. Thin Layer Chromatography of Delonix regia (Boojer .Hook.). Raf., seeds 
various extracts 
                                  
HPTLC FINGER PRINT PROFILE 
HPTLC Finger print Data of Ethanolic Extract of Delonix regia ( Boojer .Hook.). 
Raf., High performance thin layer chromatography (HPTLC) finger printing was 
performed with the ethanol extract of Delonix regia ( Boojer .Hook.) The chromatographic 
conditions were carried as detailed in material and method of this study. There were 5 
peaks observed with different Rf Values and different heights. Percentage of areas was also 
obtained from the chromatogram. 
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SOLVENT SYSTEM 
Table 18. Solvent system of HPTLC for EEDR 
Extract Solvent system 
Ethanol Hexane: Ethyl acetate: Chloroform: Methanol: Formic acid (2:3:5:0.5:0.5) 
 
                                                                    
 
                                               Fig 25. HPTLC for EEDR 
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            Fig 26. Chromatographic Finger Printing Analysis for EEDR 
Table 19. HPTLC profile of EEDR 
S. No Rf Height Area (%) 
1 0.11 29.1 861.9 
2 0.20 2.3 23.7 
3 0.25 3.7 100.2 
4 0.32 1.8 27.0 
5 0.41 1.8 55.2 
6 0.48 1.5 32.1 
7 0.65 4.1 53.7 
8 0.67 7.6 111.2 
9 0.68 8.0 144.0 
10 0.74 37.7 701.2 
 
  
Results and discussion 
 
Dept. Of Pharmacognosy, MMC. Page 89 
 
PHARMACOLOGICAL STUDIES  
SELECTION OF ACTIVE EXTRACT 
RESULTS IN-IN VITRO ANTIOXIDANT ACTIVITY 
DPPH assay (2, 2-DiPhenyl-1-PicrylHydrazyl) 
Table 20. The % inhibition of radical scavenging activity   
S. No Concentration (µg/ml) 
Standard 
BHT (butylated 
hydroxyl toluene) 
Hexane 
Extract 
Ethyl 
acetate 
Extract 
Ethanol 
Extract 
Aqueous 
Extract 
1 200 33.62 19.12 24.33 30.97 14.16 
2 400 39.31 23.59 29.62 36.09 18.21 
3 600 85.97 35.22 62.47 79.75 22.69 
4 800 90.53 42.01 68.92 82.68 30.19 
5 1000 93.76 49.90 74.38 89.51 36.90 
IC50 µg/ml 417 995 574.94 455 1474 
   
 
     Fig 27. Graphical representation of the % inhibition of radical scavenging activity   
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RESULTS IN-IN VITRO ANTI DIABETIC ACTIVITY 
α-AMYLASE INHIBITION ASSAY 
Table.21. Results in vitro anti – diabetic activity  
S. No Concentration (µg/ml) 
Standard 
(Acrabose) 
Hexane 
extract 
Ethyl 
acetate 
extract 
Ethanol 
extract 
Aqueous 
extract 
1 200 31.53 12.35 22.34 27.94 9.07 
2 400 67.38 14.07 28.02 48.05 12.01 
3 600 72.49 16.38 34.32 57.04 14.36 
4 800 78.53 30.46 42.27 63.08 16.28 
5 1000 82.92 20.05 48.43 65.26 18.45 
IC50 374.436 1561 1049.19 550.29 3702 
 
 
                  Fig 28. Graphical representation of the α-amylase inhibition assay  
0
10
20
30
40
50
60
70
80
90
0 200 400 600 800 1000 1200
%
In
hi
bi
tio
n
Concentration µg/ml
STANDARD
HEXANE EXTRACT
ETHYL ACETATE EXTRACT
ETHANOL EXTRACT
AQUEOUS EXTRACT
Results and discussion 
 
Dept. Of Pharmacognosy, MMC. Page 91 
 
RESULTS IN-IN VIVO ANTIDIADETIC ACTIVITY 
Effect of ethanolic extract of Delonix regia (Boojer .Hook.). Raf., on blood glucose 
level 
Various studies show that a number of plant extracts effectively reduced the blood 
glucose levels in streptozotocin induced rats. Till date, the antidiabetic activity of seeds of 
Delonix regia (Boojer .Hook.). Raf., has never been reported.    
Acute study  
The antidiabetic effect of ethanolic extract at the dose of 200mg/kg and 400mg/kg 
produced a dose dependent hypoglycaemia on streptozotocin induced diabetic rats. It is 
clear from the data that the blood glucose levels of control diabetic animals continued to 
increase whereas extract treated diabetic rats showed significantly reduced levels.  
Maximum reduction of blood glucose level was achieved by the ethanolic extract, 
400mg/kg from 0 hours to 24 hours respectively, whereas ethanol extract at the dose of 
200mg/kg showed a slightly lower effect. 
Table 22. Effects of EEDR On blood glucose level in streptozotocin induced diabetic 
rats (mg/dl)-acute study. 
Treatment 0 hr 1st hr 3rd hr 5th hr 7th hr 24th hr 
Group I 83±1.3 93±1.6 102±1.2 112±1.8 99±1.1 101±1.9 
Group II 372±0.4 374±1.1 385±0.2 390±1.5 407±1.8 431±2.1 
Group III 342±1.2 315±1.4 288±1.7 246±2.3* 225±1.2* 198±1.8* 
Group IV 352±2.1 348±2.2 332±2.1 276±1.3* 252±1.6* 232±1.6* 
Group V 334±1.4 329±0.8 297±1.3 262±2.3* 233±2.2* 210±2.3* 
One way ANOVA values are expressed as mean ±SD n = 6 
*P < 0.05 compared to diabetic control 
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Note:   
 Group I  Normal control 
 Group II  Diabetic control 
 Group III  Standard drug (Glibenclamide 3mg/kg) 
 Group IV  Ethanolic extract of Delonix regia 200mg/kg 
 Group V  Ethanolic extract of Delonix regia 400mg/kg 
   
 
   Fig 29. Graphical representation of blood glucose level in study groups-acute study 
 Group I compared with Groups II, III, IV, V 
 Group II compared with Groups III, IV, V 
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Chronic study 
 Chronic administration of Delonix regia (Boojer .Hook.). Raf., extracts to 
streptozotocin induced diabetic rats for 28 days produced a significant blood glucose 
reduction. A significant reduction was observed right from 1st week by ethanolic extract 
which was comparable with that standard drug, Glibenclamide (3mg/kg). 
Table 23. Effects of EEDR On blood glucose level in streptozotocin induced diabetic 
rats (mg/dl)-chronic study. 
Treatment 0 day 7th day 14th day 21st day 28th  day 
Group I 90±1.4 96±1.3 100±1.2 99±1.2 93±1.7 
Group II 264±1.4 278±1.6 284±0.8 290±1.1 307±1.9 
Group III 250±0.9 248±0.5 200±1.3* 182±1.3* 148±1.2* 
Group IV 278±1.3 274±2.7 220±1.9* 198±1.3* 187±1.5* 
Group V 270±1.2 261±2.3 206±1.5* 186±2.5* 173±1.6* 
One way ANOVA values are expressed as mean ±SD n = 6 
*P < 0.05 compared to diabetic control 
Note:   
 Group I  Normal control 
 Group II  Diabetic control 
 Group III  Standard drug (Glibenclamide 3mg/kg) 
 Group IV  Ethanolic extract of Delonix regia 200mg/kg 
 Group V  Ethanolic extract of Delonix regia 400mg/kg 
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Fig 30. Graphical representation of blood glucose level in study groups
 Group I compared with Groups II, III, IV, V
 Group II compared with Groups III, IV, V
Changes in Body weight
Table 24. Changes in Body Weight (grams)
Treatment 0 day
Group I 121±6.68
Group II 127.12±5.51
Group III 134.28±4.11
Group IV 140.51±3.64
Group V 147.17±9.47
One way ANOVA values are expressed as mean ±SD 
*P < 0.05 compared to diabetic control
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 7th day 14th day 21st day
 125.67±6.68 131.67±6.68 123.67±6.68
 133±6.33 147.38±3.25 148.26±3.25
 121.01±3.18 115.47±1.71* 109.19±6.15*
 135.47±5.48 123.24±2.31* 112.35±8.48*
 129.17±3.49 120.54±5.47* 107.68±4.67*
(n = 6) 
 
Group III Group IV Group V
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-chronic study  
 28th  day 
 127.67±6.68 
 130.57±4.15 
 100.87±7.54* 
 107.95±3.18* 
 103.91±1.26* 
0 day
7th day
14th day
21st day
28th  day
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Note:   
 Group I  Normal control
 Group II  Diabetic control
 Group III  Standard drug (Glibenclamide 3mg/kg)
 Group IV  Ethanolic extract of 
 Group V  Ethanolic extract of 
 
                 Fig 31. Graphical representation of changes in body weight (grams)
 Group I compared with Groups II, III, IV, V
 Group II compared with Groups III, IV, V
At the end of 28
weight of 67% at 200mg/kg and 76% at 400mg/kg compared to diabetic control. On the 
other hand, Glibenclamide produced a sig
ethanol extracts brought about 54% at 200mg/kg and 57% at 400mg/kg.     
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th day, ethanolic extracts produced a significant reduction of body 
nificant blood glucose reduction of 65% and the 
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Effect of ethanolic extract of Delonix regia (Boojer .Hook.). Raf., seeds on 
plasma lipid profile  
Table 25. Plasma lipid profile 
Treatment 
Total 
cholesterol 
(mg/dl) 
HDL 
cholesterol 
(mg/dl) 
LDL 
cholesterol 
(mg/dl) 
VLDL 
cholesterol 
(mg/dl) 
Triglyceride 
(mg/dl) 
Group I 94.66±5.8 48.00±4.17 77.40±4.46 26.50±2.58 81.16±6.24 
Group II 215±4.84 27.50±3.30 169.00±5.51 58.83±4.57 190.50±9.62 
Group III 90.50±12.78 51.83±3.97 85.83±4.44* 27.66±4.45* 79.17±4.44* 
Group IV 101.83±4.62 48.00±4.51 123.83±5.87* 31.66±4.45* 96.16±5.45* 
Group V 95.33±5.27 50.16±4.79 92.16±6.01* 29.66±4.45* 90.17±4.91* 
One way ANOVA values are expressed as mean ±SD n = 6 
*P < 0.05 compared to diabetic control 
Note:   
 Group I  Normal control 
 Group II  Diabetic control 
 Group III  Standard drug (Glibenclamide 3mg/kg) 
 Group IV  Ethanolic extract of Delonix regia 200mg/kg 
 Group V  Ethanolic extract of Delonix regia 400mg/kg 
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                   Fig 32. Graphical representation of lipid profile in study groups 
 Group I compared with groups II, III, IV, V. 
 Group II compared with groups III, IV, V. 
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HAEMATOLOGICAL PARAMETERS 
Haematological parameters of ethanolic extract of Delonix regia (Boojer .Hook.). 
Raf., seeds 
Table 26. Haematological parameters 
Parameters Group I Group II Group III Group IV Group V 
RBC(cells/cumm) 6.77±0.24 4.94±0.24 6.52±0.08 5.91±0.01 6.21±0.12 
WBC(cells/cumm) 7.53±0.12 11.05±0.51 7.62±0.14 7.89±0.25 7.58±0.51 
Lymphocytes% 48.33±0.45 39.21±0.23 47±0.13 46.15±0.51 49.21±0.34 
Monocytes% 4.17±0.14 5.81±0.61 4.27±0.09 4.87±0.21 4.34±0.15 
Eosinophils% 2.06±0.74 1.64±0.21 1.89±0.04 1.74±0.84 2.04±0.46 
Neutrophils% 45.42±0.19 54.14±0.53 47.05±0.14 46.01±0.17 45.04±0.08 
Basophils% 0.00±0.00 1.33±0.57 0.12±0.04 0.25±0.51 0.10±0.34 
PCV% 41.56±0.14 35.07±0.01 40.05±0.11 39.09±0.42 41.24±0.45 
Hb(g/dl) 13.7±0.45 9.3±0.15 12.2±0.65 11.90±0.15 12.8±0.75 
One way ANOVA values are expressed as mean ±SD n = 6 
*P < 0.05 compared to diabetic control 
Note:   
 Group I  Normal control 
 Group II  Diabetic control 
 Group III  Standard drug (Glibenclamide 3mg/kg) 
 Group IV  Ethanolic extract of Delonix regia 200mg/kg 
 Group V  Ethanolic extract of Delonix regia 400mg/kg 
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       Fig 33. Graphical representation of Haematological parameters in study groups 
 
 Group I compared with groups II, III, IV, V. 
 Group II compared with groups III, IV, V. 
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HISTOPATHOLOGICAL EXAMINATION OF PANCREAS
                    Fig 34. Group I
                                                   
                Fig 37. Group IV
 Group I  Normal control
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ISOLATION AND CHARACTERIZAITION  
COLUMN CHEROMATOGRAPHY 
The elutes obtained from silica gel Column chromatography of Ethanolic extract with 
different fractions are tabulated in Table. 
Table 27. Column chromatography of EEDR 
S. No Eluent Solvent ratio Fractions 
1 Ethyl acetate 100% 1 – 3 
2 Ethyl acetate: ethanol 90:10 4 – 6 
3 Ethyl acetate: ethanol 80:20 7 – 9 
4 Ethyl acetate: ethanol 70:30 10 – 12 
5 Ethyl acetate: ethanol 60:40 13 – 15 
6 Ethyl acetate: ethanol 50:50 16 – 18 
7 Ethyl acetate: ethanol 40:60 19 – 21 
8 Ethyl acetate: ethanol 30:70 22 – 24 
9 Ethyl acetate: ethanol 20:80 25 – 27 
10 Ethyl acetate: ethanol 10:90 28 – 30 
11 Ethanol 100% 31 – 33 
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THIN LAYER CHROMATOGRAPHY 
Solvent system 
Hexane: Ethyl acetate: water in 3.5:2.5:0.5 
Table 28. Thin layer chromatography of isolated fractions of EEDR 
S. No Fractions Compounds Rf  value 
1 1 - 3 - - 
2 4 - 6 - - 
3 7 - 9 - - 
4 10 – 12 - - 
5 13 – 15 - - 
6 16 – 18 - - 
7 19 – 21 - - 
8 22 – 24 - - 
9 25 – 27 - - 
10 28 – 30 Compound – 1 – 7 
0.30 
0.50 
0.62 
0.76 
0.80 
0.87 
0.91 
11 31 - 33 Compound – 1 – 7 
0.30 
0.50 
0.62 
0.76 
0.80 
0.87 
0.91 
The Rf  value of the compound 1 – 7 was found to be 0.30, 0.50, 0.62, 0.76, 0.80, 0.87, 0.91 
Results and discussion 
 
Dept. Of Pharmacognosy, MMC. Page 103 
 
SPECTRAL ANALYSIS 
The compound obtained with the ethanolic extract has been identified and spectral data 
were depicting in the figures  
 
 
                                 Fig 39. Compound:  1 – 7 IR spectra 
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Table 29. IR spectroscopy of Compound:  1 – 7 (IR υ cm-1: Nujol mull) 
Wave numbers cm-1 Intensity Type 
1238 Moderate peak Phenol 
800 – 720 Moderate peak O - substituted benzene 
2915 Moderate peak Benzene 
1055 Sharp peak C – O – C stretching 
1600 – 1900 Moderate Peak >C = O Carbonyl group 
2810 Moderate peak C – H stretching in CH3 
3346 Moderate peak OH 
1448 Moderate peak Aromatic C = C stretching 
1655 Sharp peak Isolated C=C 
1473 Moderate Peak C – H stretching 
1379 Moderate Peak C – H methyl 
2193 Sharp peak, weak band C ≡ C 
968– 704 Sharp peak -CH = CH2 
600 – 800 Moderate peak Halogen 
2917 Sharp peak Aliphatic CH 
2495 Sharp peak OH acid 
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Spectral analysis of compounds Compound:  1 – 7 
  
 
                                       Fig 40. Compound-I GC-MS spectra 
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                          Fig 41. Compound-II GC-MS spectra 
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                                    Fig 42. Compound-III GC-MS spectra 
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                          Fig 43. Compound-IV GC-MS spectra 
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                               Fig 44. Compound-V GC-MS spectra 
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                             Fig 45. Compound-VI GC-MS spectra 
 
 
 
Results and discussion 
 
Dept. Of Pharmacognosy, MMC. Page 111 
 
  
 
                                    Fig 46. Compound-VII GC-MS spectra 
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GC-MS report showed the presence of seven compounds in the fraction 28-33. In 
future isolated fraction 28-33 will be further fractionated, characterized and studied for its 
activity.    
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9. SUMMARY AND CONCLUSION 
The project entitled “Pharmacognostical, Phytochemical and 
pharmacological studies on Delonix regia (Boojer .Hook.) Raf.,” seeds, 
(Leguminosae) has been achieved by the following results. 
 The literature survey showed that only very scrappy information was available on 
this plant. With the scantly information on this plant and its folklore claim to be 
used for diabetic but has not been scientifically reported.  
 In pharmacognostical studies authentication plays an important key. The Delonix 
regia (Boojer .Hook.) Raf., was collected from Nugambakkam, chennai and 
authenticated by M. Palanisamy, Scientist ‘D’- In – Charge, Botanical Survey of 
India, Coimbatore. 
 The pharmacognostical parameters were studied. Such as macroscopy, microscopy, 
powder microscopy. Histochemical studies and physicochemical constants to 
established.    
 The qualitative and quantitative analysis was carried out to identify inorganic 
elements present in the plant. The qualitative and quantitative analysis of toxic 
heavy metals like cadmium, arsenic, lead and mercury were within the WHO limits 
and ensure the safety of the drug.    
 The coarse powder was extracted by Hexane, Ethyl acetate, Ethanol by successive 
solvent extraction by hot percolation method and aqueous extract by cold 
maceration. 
 The preliminary phytochemical screening of various extract and powder of the 
plant has revealed the presence of constituents in ethanolic extract like flavonoids, 
saponins, steroids and triterpenes.  
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 Qualitative chromatographic analysis – TLC for various extracts was carried out 
and HPTLC for ethanolic extract to conformed the  phytoconstituents present. 
 In vitro studies,  DPPH radical scavenging assay and α – amylase inhibition assay 
performed for the selection of the bio active extract. Accordingly, the EEDR was 
possess antidiabetic activity. So selected for in vivo studies.   
 The acute toxicity study was done. Based on this study as per OECD guidelines 
425, the ethanolic extract was found to be very safe up to 2000mg/kg. Efficacy of 
the extract was screened by evaluation antidiabetic activity. 
 Antidiabetic activity was assessed by streptozotocin induced non – insulin 
dependent diabetic mellitus. The parameters studied were oral glucose tolerance 
test (OGTT), hypolipidemic activity, blood glucose level, body weight changes, 
haematological parameters and histopathological studies. 
 All parameter revealed the most effective EEDR was selected for column 
chromatographic separation in an attempt to isolate the compounds. The compound 
was isolated by column chromatography and then subjected to thin layer 
chromatography followed by spectral analysis. It was identified as seven 
compounds.  
 From the above mentioned studies it can be concluded that the pharmacognostical 
reports generated will be useful for the proper identification of plant and also to 
differentiate it from closely related species and adulterants. With the support of in 
vitro studies and phytochemical screening the ethanolic extract were subjected to in 
vivo studies. The EEDR showed the significant antidiabetic activity.  
 Further studies were focused on isolation and characterization of the 
phytoconstituents is responsible for antidiabetic activity.   
  
 
 
 
 
REFERENCES 
 
 
 
 
 
 
 
References 
 
Dept. Of Pharmacognosy, MMC. Page 115 
 
10. REFERENCES 
1. Irfan ali khan, Atiya Khanum. Herbal therapy for Diabetes, 1st edition. Ukaaz 
Publications. 2007; 87: p. 119-20. 
2. Rajiv K Sinha. Ethnobotany: The Renaissance of traditional Herbal medicine. 
Inashree Publishers. Jaipur. 1996; p. 155.     
3. Varro E Tyler, Lynn R Brady, James E Robbers. Pharmacognosy. 8th edition. 1981; 
p. 1. 
4. Nunn, John. Ancient Egyptian Medicine. University of Oklahoma Press. 2002; p. 
151. 
5. Unschuld, Paul, Huang Di Nei Jing. Knowledge, Imagery in an Ancient Chinese 
Medica Text. University of California Press. 2003; p. 286. 
6. Robson, Barry & Baek, O K. The Engines of Hippocrates: From the Dawn of 
Medicine to Medicinal and Pharmaceutical Informatics. 2009; p. 50. 
7. Cravotto G, Boffa L, Genzini L, Garella D. “Phytotherapeutics: an evalution of the 
potential of 1000 plants”. J Clin Pharm Ther. 2010; 35 (1): p. 11-48. 
8. Kala, Chandra Prakash, Sajwan. “Revitalilzing Indian systems of herbal medicine 
by the National Medicinal Plants Board through institutional networking and 
capacity building”. Current Scienc. 2007; 93 (6): p. 797-806. 
9. Saad, Bashar & Said, Omar. Greco - Arab and Islamic Herbal Medicine: 
Traditional System, Ethic, Safety, Efficacy and Regulatory Issues. 2011; p. 80. 
10. Jone B E. Pharmaceutical capsules. 2nd edition. Edited by Podczeck F, John B E, 
Pharmaceutical Press. 2004; p. 91,242,449. 
11. Bhutani K K. Herbal medicines an Enigma and Challenge to Science and directions 
foe new initiatives. Indian Journal of Natural Products. 2003; 19 (1): p. 3. 
References 
 
Dept. Of Pharmacognosy, MMC. Page 116 
 
12. Chaudhury R R. Herbal Medicine for human. New Delhi. World Health 
Organization. 1992; p. 51-57. 
 
13. Patel P M, Patel N M, Goyal R K. Quality control of erbal Products. The Indian 
Pharmacist. 2006; 5 (45): p. 26-30. 
14. Angell M, Kassirer J P. Alternative medicine. The risk of untested and unregular 
remedies. New England Journal of Medicine. 1998; 339: p. 839-84. 
15. A Wang, D V C. Quality control and good manufacturing practises: Safety and 
efficacy of commercial herbals. Food Drug Law Institute. 1997; p. 341-44. 
16. Herb palace, History of Herbal Medicine Available 
in:www.herbpalace.com/alternative medicine/herbal-medicine html. [Acessed on 
8/8/2011].   
17. Dr. D K Bhatt, Dr. Aparna Raj, Kiran Bhatt. Herbal and medicinal plants of India. 
1st edition Shree Publishers & Distributors New Delhi, India. 2007; p. 7 - 17. 
18. Pharmacognosy. Dr. C K Kokate, A P Purohit, S B Gokhale. 46th edition. Nirali 
Prakashan. Pune. 2010. 
19. Dr. V Sheshiah. A hand book on Diabetes Mellitus. 2nd edition. All India Publisher 
& Distributors. Regd. Medical book Publishers. Chennai. New Delhi.  
20. Lippincott’s illustrated reviews Pharmacology. 5th edition. Michelle A, Clark, 
Richard Finkel, Jose A Rey, Karen Whalen.   
21. Williams Textbook of Endocrinology. 12th edition. Elsevier Publishers. 
22. Simple treatment to curb diabetes. Fikri Zaki Muhammadi on 2014- 01- 2014. 
23. Hand book of Pediatric drug therapy and immunization. R K Suneja. 2nd edition. 
Reed Elsevier. India Private limited. p. 169 
24. http://www.uscfhealth.org/conditions/diabetes/treatment.html  
References 
 
Dept. Of Pharmacognosy, MMC. Page 117 
 
25. http://www.medicinenet.com/diabetes_treatment/article.htm 
26. H P Hang, M M Dale, J M Ritter, R J. Flower Pharmacology. 6th edition. 2007; p. 
397. 
27. Michelle A, Clark, Richard Finkel, Jose A, Rey and Karen Whalen. Pharmacology. 
5th edition. 2012; p. 302. 
28. Sarojini Sarangapani, Manavalan Rajappan. Pharmacognostical and pharmaceutical 
characterization of Delonix regia- a novel matrix forming natural plymer. 2012; 2 
(3): p. 567-573. 
29. Barhate A N, Virkar A R, Beldar G B, Shinde S. Evaluation of Delonix regia seed 
gum as suspending agent in paracetamol suspensions. International Journal of 
Pharma Tech Research. 2014; 6(2): p. 530-536. 
30. Kavitha Sama, Xavier Ergeese Raja A. Preliminary phytochemical screening of 
root bark of Delonix regia. 2011; 2(10): p. 42-43. 
31. Samar S, Azab, Mohamed Abdeil-Daim, Omayma A, Eldahshan. Phytochemical, 
cytotoxic, hepatoprotective and antioxidant properties of Delonix regia leaves 
extract. Medicinal Chemistry Research. 2013. 
32. Ravi Kumar A, Rijwana Shaik, Yeashwanth D. Phytochemical evaluation of 
Delonix regia Samanea saman Bauhinia variegata. International Journal of 
Research in Pharmacy and Chemistry. 2013; 3(4). 
33. Fatmawaty, Fadilah, Hendry Astuti. Antimalarial activity of Delonix regia on mice 
with Plasmodium berghei. Journal of Natural Products. 2013; 6: p. 61-66. 
34. Anindita Biswas, Ganga Rao Battu. Potential hepatoprotective and antioxidant 
activity of Delonix regia flower extract against paracetamol induced liver toxicity 
in rats. International Journal of Biological Pharmaceutical and Research. 2014; 
5(8): p. 689-700. 
References 
 
Dept. Of Pharmacognosy, MMC. Page 118 
 
35. Rajabhau S Shiramane, Karankumar V Biradar, Basavaraj V Chivde. In vivo 
antidiarrhoeal activity of ethanolic extract of Delonix regia flowers in experimental 
induced diarrhoea in Wistar albino rats. International Journal of Research in 
Pharmacy and Chemistry. 2011; 1(3).   
36. Nilam Yado, Charles Priya, Kokati Venkata Bhaskara Rao. Carbohydrate 
hydrolyzing enzyme inhibitor property, antioxidant and phytochemical analysis of 
Cassia auriculata, Delonix regia and Vinca rosea Linn: an in vitro study. Journal 
of Applied Pharmaceutical Sciences. 2015; 5(5): p. 018-027.  
37. Mariajancyrani J, Chandranmohan G, Saravanan P, Saivaraj S. In vitro antioxidant 
potential of Delonix regia leaves. 2013; 2(6): p. 468-71. 
38. Mohad Asif Khan, Amit Saxena, Farhheen Tabassum Fatima, Gaurav Sharma, 
Veerana, Gound, Asif Hussain. Study wound healing activity of Delonix regia 
flowers in experimental animal models. American Journal of Pharm Tech Research. 
2012; 2(2). 
39. Ghulam Shabir, Farooq Anwar, Bushra Sultana, Zafar M Khalid, Muhammad 
Afzal, Qaiser M, Khan, M Ashrafuzzaman. Antioxidant and antimicrobial attributes 
and phenolics of different solvent extracts from leaves, flowers and bark of gold 
mohar (Delonix regia (Bojer ex Hook.) Raf.,). Molecules. 2011; 16: p. 7302-73019.     
40. Shanmukha I, Harshil Patel, Jignesh Patel, Riyazunnisa. Quantification of total 
phenol and flavonoid content of Delonix regia flowers. 2011; 3(1): p. 280-83. 
41. Consolacion Y, Ragasaa, Joy G, Hofilena. Antimicrbial coumarin derivative from 
Delonix regia. The manila journal of sciences. 2011; 7(1): p. 7-11. 
42. Aly M, Ei-Sayed, Shahira M, Ezzat, Maha M, Salama, Amany A, Dleem. 
Hepatoprotective and cytotoxic activities of Delonix regia flowers extracts. 
Pharmacognosy Journal. 2011; 3(19). 
References 
 
Dept. Of Pharmacognosy, MMC. Page 119 
 
43. Jyothi M. Veigas, Mandayam S, Narayan, Kotamballi N, Chidambaramurthy, 
Bhagyalakshmi Neelwarne. Antioxidant efficacies of floral extracts of Delonix 
regia Rafin. International Journal of Biomedical and Pharmaceutical Sciences. 
2007; 1(1): p. 73-82. 
44. Sarojini Sarangapani, Manavalan Rajappan. Pharmacognostical and pharmaceutical 
characterization of Delonix regia- a novel matrix forming natural plymer. 2012; 
2(3): p. 567-73. 
45. Barhate A N, Virkar A R, Beldar G B, Shinde S. Evaluation of Delonix regia seed 
gum as suspending agent in paracetamol suspensions. International Journal of 
Pharma Tech Research. 2014; 6(2): p. 530-36. 
46. Flexi Adje, Yves F Lozano, Emmanuelle Meudec, Paul Lozano, Augustin Adima, 
Georges Agbo N, Zi, Emile M Gaydou. Anthocyanin characterization of pilot plant 
water extracts of Delonix regia flowers. Molecules. 2008; 13: p. 1238-45. 
47. Rajabhau S Shiramane, Karankumar V Biradar, Basavaraj V Chivde. In vivo 
antidiarrhoeal activity of ethanolic extract of Delonix regia flowers in experimental 
induced diarrhoea in Wistar albino rats. International Journal of Research in 
Pharmacy and Chemistry. 2011; 1(3).   
48.  Fatmawaty, Fadilah, Hendry Astuti. Antimalarial activity of Delonix regia on mice 
with Plasmodium berghei. Journal of Natural Products. 2013; 6: p. 61-66. 
49. Rozina Parul, Md. Jahir Alam, Md. Sohel Rana. Antinociceptive and cytotoxic 
potential of ethanolic extract of Delonix regia (leaves). Indian Journal of 
Pharmaceutical and Biological Research. 2014; 2(1): p. 55-61. 
50. Nilam Yado, Charles Priya, Kokati Venkata Bhaskara Rao. Carbohydrate 
hydrolyzing enzyme inhibitor property, antioxidant and phytochemical analysis of 
References 
 
Dept. Of Pharmacognosy, MMC. Page 120 
 
Cassia auriculata, Delonix regia and Vinca rosea Linn: an in vitro study. Journal of 
Applied Pharmaceutical Sciences. 2015; 5(5): p. 018-027.  
51. Kavitha Sama, A Xavier Vargeese Raja, R Hiranmai Yadav. Antibacterial and 
pharmacological evaluation of Delonix regia root bark. International Journal of 
Pharmacy and Life Sciences. 2012; 3(4): p. 1628-30. 
52. Sachidanandha Swamy H C, Asha M M, Chaithra M, Vivek M N, Yashoda 
Kambar, Prashith Kekuda T R. Antibacterial activity of flower extract of 
Caesalpinia pulcherrima, Delonix regia and Peltaphorum ferrugineum against 
urinary tract pathogens. Journal of Applied Pharmaceutical Sciences. 2014; 3(4): p. 
80-83. 
53. Dinananth and antioxidant D Patil, Dnyandeo K Mhaske, Machindra A Patare, 
Gurumeet C Wadhawa. Anti-inflammatory study of leaves and root Delonix regia. 
International Journal of Pharmaceutical and Chemical Sciences. 2014; 3(1). 
54. Shiramane Rajabhau S, Chivde Basavaraj V, Kamshetty Manoj V, Biradar Karna 
Kumar V, Asif Khan. Gastroprotective activity of ethanolic extract of Delonix 
regia flowers in experimental induced ulcer in Wistar albino rats. International 
Research Journal of Pharmacy. 2011; 2(5): p. 234-38. 
55. Anindita Biswas, Ganga Rao Battu. Potential hepatoprotective and antioxidant 
activity of Delonix regia flower extract against paracetamol induced liver toxicity 
in rats. International Journal of Biological Pharmaceutical and Research. 2014; 
5(8): p. 689-700. 
56. Ahmed Salman, Sabzwari Toseef, Hasan Muhammad Mohtasheemul, Azhar Iqbal. 
Antiemetic activity of leaves extracts of five leguminous plants. International 
Journal of Research in Ayurveda and Pharmacy. 2012; 3(2). 
References 
 
Dept. Of Pharmacognosy, MMC. Page 121 
 
57. Vivek M N, Sachidanandha Swamy H C, Manasa M, Pallavi S, Yashoda Kambar, 
Asha M M, Chaithra M, Prasanthi Kekuda T R., Mallikarjun N, Onkarappa R. 
Antimicrobial and antioxidant ativity of leaf and flower extract of Caesalpinia 
pulcherrima, Delonix regia and Peltaphorum ferrugineum against urinary tract 
pathogens. Journal of Applied Pharmaceutical Sciences. 2013; 3(08): p. 064-071. 
58. Mohad Asif Khan, Amit Saxena, Farhheen Tabassum Fatima, Gaurav Sharma, 
Veerana, Gound, Asif Hussain. Study wound healing activity of Delonix regia 
flowers in experimental animal models. American Journal of Pharmtech Research. 
2012; 2(2). 
59. Tagalpallewar V R, R S Wanare, Tayade A M, Pangarkar P A. Antidiabetic activity 
of Delonix regia leaves in normal and alloxan induced diabetic mice. International 
Journal of Pharmaceutical Research and Development. 2014; 6(1): p. 123-26. 
60. Ghulam Shabir, Farooq Anwar, Bushra Sultana, Zafar M Khalid, Muhammad 
Afzal, Qaiser M Khan, M. Ashrafuzzaman. Antioxidant and antimicrobial attributes 
and phenolics of different solvent extracts from leaves, flowers and bark of gold 
mohar (Delonix regia (Bojer ex Hook.) Raf.,). Molecules. 2011; 16: p. 7302-19.     
61. Mohamed Z M, Salem, Ahmed Abdel-Megeed, Hayssam M Ali. Stem wood and 
bark extracts of Delonix regia (Boj. Ex. Hook): Chemical analysis and antibacterial 
, antifungal, and antioxidant properties. Bio Resources. 2014; 9(2): p. 2382-95.  
62. Ode O J, Ajagbonna O  P, Madubuike S A, Oladele G M, Ayuba U B. Journal of 
Pharmacy and Biological Sciences. 2013; 7(3): p. 21-28. 
63. Consolacion Y, Ragasaa, Joy G, Hofilena. Antimicrbial coumarin derivative from 
Delonix regia. The Manila Journal of Sciences. 2011; 7(1): p. 7-11. 
64. Samersh Pal Roy, Kamlesh Prajapati, Ramji Gupta, Dipanwita Bhadra, Nikunj 
Patel, Archana Baitwala, Gautam Sonara, Neerva Gheewala, T Kannadasan. 
References 
 
Dept. Of Pharmacognosy, MMC. Page 122 
 
Evaluation of antiulcer effects of ethanolic extract of Delonix regia flowers. Indian 
Journal of Research in Pharmacy and Biotechnology. 2013; 1(3). 
 
65. Pacheco-Aguirre J, Rosado-Rubio G, Betancur-Ancona D, Chel-Guerrero L. 
Physicochemical properties of carboxy methylated flamboyant (Delonix regia) seed 
gum. CyTA - Journal of Food. 2010; 8(3): p. 169–176. 
66. Shanmukha I, Harshil Patel, Jignesh Patel, Riyazunnisa. Quantification of total 
phenol and flavonoid content of Delonix regia flowers. International Journal of 
Chem Tech Research. 2011; 3(1): p. 280-283.  
67. Chopra R N, Nayar S L, Chopra I C. Glossary of Indian Medicinal Plants CSIR, 
New Delhi. 1956; p. 92. 
68. Sumitra Singh, Sonia Naresh Kumar. A Review: Introduction to Genus Delonix 
World Journal of Pharmacy and Pharmaceutical Sciences. 2014; 3 (6). 
69. Arora Arun, Sen Rajendra. Singh Jitendra. Fatty acid composition of Delonix regia 
(Gulmohar) seed oil from arid zone of Rajasthan. Journal Ind. Council Chem. 2010; 
27(2): p. 150- 152. 
70. Chopra R N, Nayar S L, Chopra I C. Glossary of Indian Medicinal Plants CSIR. 
New Delhi. 1956; p. 92. 
71. http://zipcodezoo.com/Key/Plantae/DelonixGenus.asp.Zipcodezoo. com. Reterived 
on July 28. 2012. 
72. Hamdoon Mohammed (2009). Natural and synthetic flavonoid derivatives with 
potential antioxidant and anticancer activities. University of Saarland, Saarbrücken, 
Germany, Retervied on January 1. 2012. 
73. Jahan Israt, Rahman Mohamaad S, Rahman Mohammad Z, Kaisar Mohammad  
References 
 
Dept. Of Pharmacognosy, MMC. Page 123 
 
A, Islam Mohamaad S, Wahab Abdul, Rashid Mohammad A. Chemical and 
biological investigation of Delonix regia (Bojer ex. Hook) Raf. Acta 
Pharmaceutica. 2010; 60(2): p. 207-215. 
74. Jyothi M, Veigas  Mandayam S, Narayan Kotamballi N, Chidambaramurthy  
Bhagyalakshmi Neelwarne. Antioxidative Efficacies of floral petal extracts of 
Delonix Regia Rafin International Journal of Biomedical and Pharmaceutical 
Sciences. 2007. 
75. Claus Pratical Pharmacognosy.6th edition. London. Henry Kempton. 1965. 
76. Sass J E. Elements of Botanical micro technique. New York. McGraw Hill Book 
Company. Inc. 1940. 
77. Eassu K. Plant Anatomy. New York. John Wiley and Sons. 1965. 
78. Johansen D A. Plant micro technique. New York. McGraw Hill Book Co. 1940. 
79. Kokate C K. Practical Pharmacognosy. 4th edition. Delhi. Vallabh Prakashan. 2002. 
80. M A Iyengar, S C K Nayak. Anatomy of crude drugs Iyengar’s series. 12th edition. 
Manipal Press ltd. Manipal. 2012. 
81. Quality control of herbal drugs. Dr. Pulok, K Mukherjee, 4th edition. Horizons 
Publishers. 2002. 
82. Krishna Murthy K V. Methods of histochemistry. Chennai. Vishwanath Printers 
and Publishers. 1998. 
83. Pharmacopoeia of India. Delhi. Published by the Manager of Publication. 1970. 
84. Kokate C K, Purohit A P, Gokhale S B. Analytical Pharmacognosy. 23rd edition. 
Pune. Nirali Prakashnan. 2003. 
85. Quality Control Methods for Medicinal Plant Materials. WHO Geneva. Indian 
edition 2004. 
References 
 
Dept. Of Pharmacognosy, MMC. Page 124 
 
86. The Ayurvedic Pharmacopoeia of India. New Delhi. The controller of publications. 
Ministry of Health Welfare. Govt of India. 2002; Vol. 1,2, 5, 34. 
87. British Pharmacopoeia. General Medical council. London. Pharmaceutical Press. 
1968. 
88. Lira, Sergio, Peter Brush, Laurence Senak, Chi San Wu, Edward Malware. The use 
of inductively coupled plasma-optical emission spectroscopy in the determination 
of heavy metals in crospovidone and povidone as a replacement for the 
concomitant visual comparison test. Pharmacopoeial Forum. 2008; p. 34. 
89. Archa vermani. Narneet prabhat, Avinash chauhan. Physiochemical analysis of ash 
of some medicinal plants growing in Uttarkhand. Nature and Science. 2010; 8(6). 
90. J B Harborne. Phytochemical methods. A guide to modern techniques of plant 
analysis. 2nd edition. London. Chapman and Hall. 1973. 
91. Tyler V E, Brady L R, Robbers J E. Pharmacognosy. 9th edition. Philadelphia 
USA. Lea and Febrigoree. 1998. 
92. Kokate C K, Khandelwal K R, Pawar A P, Gohale S B. Practical Pharmacognosy. 
3rd edition. Nirali Prakashan. Pune. 1998.  
93. Wallis T E. Textbook of Pharamacognosy. CBS Publishers and Distributers. New 
Delhi. 1985. 
94. Dordevid S, Cakic M, Amr S. The extraction of apigenin and luteolin from the Sage 
salvia officinals L from Jordon. The scientific Journal Facta Universities. 2000; p. 
1.  
95. Raaman N. Qualitative phytochemical screening. Phytochemical techniques. New 
Delhi. New India Publishing Agency. 2000. 
96. Kokate C K, Purohit A R, Gokhale S B. Pathway to Screen phytochemical nature of 
Natural drugs. Pharmacognosy. 42nd edition. Pune. Nirali Publication. 2008. 
References 
 
Dept. Of Pharmacognosy, MMC. Page 125 
 
97. Evans W C, Trease. Texbook of Pharmcognosy. 13th edition. English language 
book society. England. 1998. 
98. Atul Shirkhedkar, Dr. S J Surana. Pharmacognosy and Phytochemistry. 2nd edition. 
Pragati books Pvt. Ltd. 2008.   
99. Indian Pharmacopoeia, 4th edition, Government of India. Ministry of Health and 
Welfare. Controller of Publications. New Delhi. 1996; Vol 2.  
100. Peter J, Houghton, Amala Raman. Laboratory hand book for the fraction of natural 
extracts. 1st edition. Springer (India) Pvt. Ltd. 2011.  
101. J. B. Harborne. Phytochemical methods. A guide to modern techniques of plant 
analysis. 3rd edition. Springer (India) pvt. Ltd. 2011. 
102. Hildebert Wagner, Sabine Bladt. Plant drug analysis. A thin layer chromatography 
atlas. 2nd edition. Springer (India) Pvt. Ltd. 2011. 
103. Dr. Vibha tendon, Dr. Akhilesh K. Verma. Chemistry of Natural products. 1st 
edition. Shree Publishers and Distributors. New Delhi. 2009. 
104. Connors K A. Fluorescence spectroscopy. A Textbook of Pharmaceutical analysis , 
3rd  edition . Singapore, John Wiley and sons (ASIA) Ptv ltd. 1982. 
105. Balakrishnan M, Dhanapal R, Vamsi M L, Sekhar K B C. Studies on 
Pharmacognostical specifications of Azima tetracantha Lam. International Journal 
of PhytoPharmacology. 2010; 1(1). 
106. Edeoga H O, Okwu D E and Mbaebie B O. Phytochemical constituents of some 
Nigeriann Medicinal plants. African Journal of Biotechnology. 2005; 4(7). 
107. Biju John, Sulaiman C T, Satheesh George and V R K Reddy. Total phenolics and 
flavonoids in selected medicinal plants from kerala. International Journal of 
Pharmacy and Pharmaceutical Science. 2014; 6(1). 
References 
 
Dept. Of Pharmacognosy, MMC. Page 126 
 
108. Lala P K. Lab manuals of Pharmacognosy. 5 th edition . Calcutta. CSI Publishers 
and Distributors. 1993. 
109. Kasture A V, Mahadik K R, Wadokar S G, More H N. Chromatography. 
Pharmaceutical analysis. 15th edition. Pune. Nirali Publication. 2006. 
110. Gurdeep R, Chatwal, Sham K Anand.  Instrumental methods of chemical analysis, 
Mumbai. Himalaya Publication House. 2007. 
111. Pradeep Goyal, Anil Kumar, Agarwal, Lakshminarasimahaiah, G K Singh. 
Antidiabetic and antihyperlipidemic effect of Borassus flabellifer in Streptozotocin 
(STZ) induced diabetic rats. World Journal of Pharmacy and Pharmaceutical 
Sciences. 2014; 4(1). 
112. Kaliaperumal Krishnaraj, Mulla Johi Nanjan Chandrasekar, Mulla Joghi Nanjan, 
Selvadurai Muralidharan, Duraikannu Manikandan. Development of sustained 
released antipsychotic tablets using novel polysaccharide isolated from Delonix 
regia seeds and its pharmacokinetic studies. Saudi Pharm Journal. 2012; 20 (3). 
113. Snehal S Patel, Rajendra S Shah, Ramesh K Goyal. Antihyerglcemic, 
antihyerlipidemic, antioxidant effects of Dihar a polyherbal formulation in 
Streptozotocin induced diabetic rats. Indian journal of Experimental biology. 2000. 
114. Rajalakshmi M, Eliza J, Cecilia Edel Priya, Nirmala A, Daisy P. Anti-diabetic 
properties of Tinospora cordifolia stem extracts on Streptozotocin- induced 
diabetic rats. African Journal of Pharmacy and Pharmacology. 2009; 3(5). 
115. S K Gupta. Drug screening methods. 2nd edition. 2009. 
116. Umamaheswari S, Leena Dennis Joseph, J Srikanth, Lavanya R. Antidiabetic 
activity of a Polyherbal formulation (DIABET). International Journal of 
Pharmaceutical Sciences. 2010; 2(1): p. 18-22.   
References 
 
Dept. Of Pharmacognosy, MMC. Page 127 
 
117. Omair Hasan Osmani, Dhanasekar Satish Sekar, K L Senthil kumar, Ram Kumar 
Sahu, Ami Troy. In vivo anti diabetic potential of Atrcarpus heterophyllus plant 
seeds in Streptozotocin induced diabetic rats. Biomedical and Pharmacology 
Journal. 2009; p. 2.    
118. Ayman M, Mahmoud. Hematological alterations in Diabetic Rats. Role of 
Adipocytokines and effect of Citrus flavonoids. Journal Experimental and Clinical 
Sciences. 2013. 
 
 
 
  
 
 
 
 
ANNEXURES 







